《Blaustein女性生殖道病理学》翻译完成
2012年底，翻译团队完成了《Blaustein女性生殖道病理学》翻译工作。本书是最好的妇科病理著作，也是我们首次翻译的巨著。全书正文1200多页，经过44名译者和11名审校专家历时18个月的艰苦努力得以完成。我们在忠于原著的基础上适当改进编排方式，便于阅读和查找。相信本书将会成为我们网站推出的又一精品译著。
名称：Blaustein原著封面
赵澄泉（Chengquan Zhao)教授邀请原著第一主编Kurman博士专门为本书中文版撰写了前言。
Preface for Chinese Translation
The trajectory of advances in gynecologic pathology over the past 35 years since the first edition of Blaustein’s Pathology of the Female Genital Tract is highlighted by the significant contributions from a number of different disciplines notably epidemiology and molecular biology. In fact, the application of molecular biologic methods in conjunction with histopathologic classifications and the natural history of disease ushers in a new approach for surgical pathology in general and gynecologic pathology in particular, which will continue to evolve in the future. continue to evolve Thus, the publication of the 6th edition of the Blaustein text marks the transition in diagnosis from a largely morphologic activity to one based upon an integrated assessment of light microscopy, immunohistochemistry and molecular biology. Finally, the emerging role of digital technology that makes an ever-increasing amount of data available at our fingertips will undoubtedly change the way we access information in the future.
Since the publication of the first edition in 1977, Blaustein’s Pathology of the Female Genital Tract has emerged as the leading textbook of gynecologic pathology and is the gold-standard reference for practicing pathologists and trainees, as well as obstetric/gynecology practitioners. As with previous editions, the 6th edition maintains a commitment to being a comprehensive text that covers the field of gynecologic pathology in depth while not sacrificing its utility as a “desk-side” text that can be referred to in every day practice. Accordingly, significant changes have been made to inform the reader of advances in research that have occurred since the last edition while at the same time enhancing its usefulness in the every day practice of gynecologic pathology.
This thoroughly updated 6th edition includes more than 1400 illustrations in color, informative tables and 22 revised chapters written by internationally recognized experts. Discussion of each specific entity is organized to include general information, etiology, and epidemiology followed by clinical features, pathologic findings, differential diagnosis, clinical behavior and treatment.
I am delighted that this book has been translated into Chinese through the efforts of Huaxia Pathology Web and that the translated version has been published by Beijing Science and Technology Press. Clearly, this book would not have been possible without the great efforts in translation by Debin Xue, Baoling Xing, Qing Li, Liping Wang, Webin Huang and many young Chinese pathologists from various different hospitals throughout China. Finally, I must express my gratitude to the prodigious work of the chief reviser, Chengquan Zhao and the co-revisers Aijun Liu, Wentao Yang and Dengfeng Cao. The entire team has produced a superb translation of the 6th edition of Blaustein’s Pathology of the Female Genital Tract, which will become a valuable resource for all Chinese pathologists.
Robert J. Kurman, M.D.
Richard W. Telinde Distinguished Professor of Gynecologic Pathology
Departments of Gynecology, Obstetrics, Pathology and Oncology
Director of Gynecologic Pathology
Johns Hopkins Hospital
Baltimore, Maryland
June 2012
中文版前言
《Blaustein女性生殖道病理学》初版发行已有35年，多学科的重大进步，尤其是流行病学和分子生物学的杰出贡献，推动妇科病理学不断前进。分子生物学方法结合组织病理学分类和疾病自然史研究为外科病理学、特别是妇科病理学开创了崭新的研究方法，并且，这种研究方法今后仍将继续发展。因此，第6版Blaustein教科书突出了诊断学研究方法变迁的特征，从以往的形态学研究为主，演变为将评估光学显微镜形态、免疫组织化学和分子生物学研究结果相结合的综合诊断方法。最后，数字技术的广泛应用，使得我们更易获取越来越多的有用数据，这必将改变我们未来获取信息的方式。
《Blaustein女性生殖道病理学》初版于1977年，很快就成为妇科病理学教科书的范本，成为临床病理医生、病理培训医生以及妇科/产科医师在实际工作中的“金标准”参考书。本书第6版与以往版本一脉相承，属于综合性教科书，涵盖妇科病理学的各个领域，既有精深的学术价值又兼顾实用性，可作为“案头”教科书，便于读者在日常工作实践中查阅参考。第6版也作出了许多重大修改，引导读者关注第5版发行之后的研究进展，同时，进一步增强了本书在妇科病理学日常实践中的实用性。
彻底更新的第6版包括1400多幅彩图（译者注：第5版全是黑白图）和信息丰富的表格，全书22章均由国际著名专家编写修订。每一种独立的疾病实体都采取统一的编排体例，先阐述基本信息、病因学、流行病学，然后讨论临床特征、病理学表现、鉴别诊断、临床行为和治疗。
欣闻华夏病理学网（www.ipathology.cn）将本书译成中文，并由北京科技出版社出版。显然，如果没有薛德彬、邢宝玲、李青、王丽萍、黄文斌和来自中国多所医院的众多年轻病理医师的共同努力，本书的翻译不可能完成。最后，感谢主审赵澄泉、副主审刘爱军、杨文涛和曹登峰作出了巨大贡献。翻译团队全体成员完成了高质量的中文版，相信本书将会成为所有中国病理医生有价值的参考书。
译者前言
女性生殖道病理学专著很多，各有所长，但其学术价值和影响力都无法超越《Blaustein女性生殖道病理学》。《Blaustein女性生殖道病理学》于1977年面世，先后六次修订再版，是妇科病理学专著的“金标准”参考书和畅销书。Kurman博士从第3版开始担任第一主编。 Kurman博士1969年毕业于纽约Syracuse Upstate医学院，在哈佛医学系统经病理住院医生和妇科病理Fellow培训，先后在AFIP，南加州大学医学院和乔治城大学任病理医生。1989年至今在约翰•霍普金斯（Johns Hopkins）大学医院工作任妇科病理组主任。他的主要研究兴趣是妇女生殖道各种肿瘤的发生机制。他是世界著名妇产科病理学家，从事病理学和妇产科病理学约40年，至今共发表专业论文约250篇，综述和书籍章节142篇，主编专业书籍12部，也是最新版《WHO女性生殖器官肿瘤分类》的第一主编（可能2014年出版）。《Blaustein女性生殖道病理学》其他两位主编Ellenson和Ronnett博士及大多编著者也均为国际著名妇产科病理专家，分别撰写各自权威的专业领域，代表国际最高专业水平，体现妇产科病理学各个领域的最新研究进展。
本书原著为2011年第6版，新版全部更新为彩色图片，新增350幅图片，共有22个章节，1446幅图片和125个总结性表格，重点突出，包含女性生殖道病理的所有内容。全书采取统一的编排体例，每一独立病种都包括概述、病因学、流行病学、临床特征、病理学表现、鉴别诊断、临床行为和治疗，条理清晰，便于阅读。本书适用于妇产科病理医生、大外科病理医生，病理科进修医生，妇产科医生，妇产科进修生，医学院校病理专业教师和学生的实际工作和学习。中国各行各业发展日新月异，病理学的发展也应与时俱进。作为一名从事临床诊断工作多年的妇科病理医生，《Blaustein女性生殖道病理学》是我日常工作中最常用的参考书，特向中国的广大病理医生强力推荐！
翻译出版此书工程浩大，许多人为此花费了大量的时间和精力。感谢华夏病理学网翻译团队的许多朋友们，他们以无私奉献和精诚合作的团队精神完成译稿。感谢国内44名热爱病理的翻译者准确的翻译以及11名国内外妇产科病理专家的精心审校。尤其感谢薛德彬（abin）医生（福建莆田学院附属医院病理科主任），他全面组织协调本书的翻译工作，并通读润色和修订了全书所有22个章节的中文翻译。没有abin和翻译团队成员的执着和勤奋、对妇产科病理的热爱和对中国病理事业的奉献精神，这部巨著的中文版不可能呈现在读者面前。同时也感谢北京科学技术出版社李金莉主任、杨帆编辑等的大力支持和辛勤工作，使得本书得以顺利出版。
我们所有翻译和审校者衷心希望大家能喜欢这本翻译巨著《Blaustein女性生殖道病理学》。如有错误恳请读者批评指正。
美国匹兹堡大学医学院病理学教授
于美国匹兹堡 2012年12月
本书也是北京科学技术出版社申报的国家重点图书之一。部分申报内容如下：
自1977年首次出版以来，本书就成为妇产科病理学领域最权威的经典著作，历来是病理诊断中的金标准。本书为2011年第7版，与上一版相比，全部更新为彩色图片，新增350幅图片，增加了很多总结性表格，所有章节分别由国际知名专家编写或修订他们最擅长的专业领域。每一专业领域均为最权威性参考资料。
每一具体疾病的编排，包括总述，病因学，流行病学，临床特征，病理学表现，鉴别诊断，临床行为，临床处理。全书统一采用这种清晰的编排格式，便于读者快速查阅。本书是病理医生和进修生培训在实际工作中的金标准，也可供妇科、产科医生和住院医生和进修生参考。
本书正文共22章，每个具体疾病的编排，均包括总述，病因学，流行病学，临床特征，病理学表现，鉴别诊断，临床行为，临床处理等知识要点。共有1400幅高质量彩色显微照片，并总结了很多实用表格，帮助读者快速查阅、学习掌握妇产科病理学的关键知识。
翻译后记
从我们签署《Blaustein女性生殖道病理学》的翻译合同至今，经过44名译者和11名审校专家历时18个月的艰苦努力，本书的翻译和校对工作已全部完成，有望于2013年6月出版。本书是妇科病理学专著的“金标准”参考书和畅销书。本书第一主编Kurman博士也是最新版《WHO女性生殖器官肿瘤》分类（预计2014年出版）的第一主编。与WHO肿瘤分类丛书相比，本书不仅包括肿瘤疾病，还包括大量非肿瘤疾病。内容更全面，知识体系更完整。
本书原著为2011年第6版，新版全部更新为彩色图片（旧版全为黑白图），新增350幅图片，共有1446幅图片和125幅总结性表格，重点突出。全书采取统一的编排体例，条理清晰。为了便于阅读，译者适当改进了编排方式，尽量使用英文缩写，以节省篇幅。书后附录包括英文缩写词表和中文索引，便于快速查找。本书适用于妇产科病理医生、大外科病理医生、病理科进修医生、妇产科医生、妇产科进修生、医学院校病理专业教师和学生的实际工作和学习提高。
本书是华夏病理学网（www.ipathology.cn）翻译团队首次完成的翻译巨著，全体译审者倾情奉献。薛德彬、邢宝玲、李青、王丽萍和黄文斌等主译人员花费了大量时间和精力；赵澄泉（审校1-6章、17章、19章、22章）、刘爱军（审校7-11章）、曹登峰（审校12-13章、20章）、杨文涛（审校14-15章）、王照明和翁保迎、李昕、李再波、郭爱桃、平波、李玲等专家在繁忙的日常工作中抽出时间精心审校；杨敏（小荷）、何诚、付长霞和李伟松等华夏病理学网管理员们给予很多帮助；王照明老师在我们译校任务紧迫之际仅用不到一周时间完成审校工作；李国霞、张晓阳、刘扬、廖林虹和黄文斌用很短时间重新翻译了第19章。在此一并感谢！同时感谢我们的家人和同事，正是她（他）们分担了大量日常事务，才使得我们在繁忙的工作之余得以积累点滴时间完成翻译。
我们希望此书的翻译版能对妇产科病理的学习和临床工作提供有益的帮助，促进国内妇产科病理的继续发展并与国际接轨。虽然我们希望此翻译版能忠实地表达原著的风格和内容，但由于病理专业知识博大精深而我们的经验水平有限，不当之处在所难免，恳请广大读者提出宝贵意见。
全体翻译和审校人员名单
（一）主译：薛德彬
副主译：邢宝玲，李青，王丽萍，黄文斌
（二）主审：赵澄泉(Chengquan Zhao)
副主审：刘爱军，杨文涛，曹登峰，王照明
（三）审校者（按章节次序排名）：
赵澄泉 (Chengquan Zhao)，李再波（Zaibo Li） Department of Pathology, University of
Pittsburgh Medical Center, PA, USA
翁保迎 (Baoying Weng) Department of Pathology, Conemaugh Health System, PA, USA
李昕 (Xin Li) Department of Pathology, University Hospitals of Cleveland, Ohio, USA
刘爱军，郭爱桃 中国人民解放军总医院病理科
曹登峰 北京大学肿瘤医院（北京肿瘤医院）病理科
杨文涛，平波 复旦大学附属肿瘤医院病理科
王照明 浙江大学医学院附属第一医院病理科
李玲 福建省肿瘤医院妇科
（四）译者名单（按章节次序排名）
1. 薛德彬 福建省莆田学院附属医院（新区）病理科
2. 邢宝玲 南京医科大学附属常州妇幼保健院病理科
3. 孔令慧 内蒙古医学院附属人民医院病理科
4. 刘杨 大庆市人民医院病理科
5. 白瑞珍 无锡市第四人民医院病理科
6. 程晔 浙江省肿瘤医院病理科
7. 尹利军 山东省潍坊市第二人民医院病理科
8. 贺红英 广西医科大学第四附属医院妇产科
9. 廖林虹 江西省赣州市妇幼保健院病理科
10. 李长平 吉林省通化市人民医院病理科
11. 朱亚宁 南京医科大学附属淮安一院病理科
12. 张正祥 安徽医科大学附属安庆市立医院病理科
13. 田卫华 广东省珠海市人民医院病理科
14. 张继平 郑州金域临床检验中心病理科
15. 王炜 广州军区广州总医院病理科
16. 杨丽英 福建省莆田学院附属医院病理科
17. 李青 南京医科大学附属南京市妇幼保健院病理科
18. 陈友权 安徽省六安市第二人民医院病理科
19. 王毅 广东省妇幼保健院病理科
20. 张宏 武警广东总队医院病理科
21. 王仁杰 江西省景德镇市第二医院
22. 高薇 济南市中心医院病理科
23. 黄文斌 南京医科大学附属南京第一医院病理科
24. 李国霞 上海市松江区中心医院病理科
25. 李旻 深圳龙华人民医院
26. 李伟松 赣南医学院病理教研室
27. 郭晓红 广东省珠海市人民医院病理科
28. 王丽萍 吉林大学中日联谊医院病理科
29. 王学菊 吉林大学中日联谊医院病理科
30. 吴琼 吉林大学中日联谊医院病理科
31. 王喆辉 吉林大学中日联谊医院病理科
32. 胡钰 吉林大学中日联谊医院病理科
33. 牛春波 吉林大学中日联谊医院病理科
34. 陈桂秋 吉林大学中日联谊医院病理科
35. 王宽松 中南大学湘雅医院病理科
36. 张晓阳 天津医科大学第二医院病理科
37. 毛瑛玉 福建医科大学附属宁德市闽东医院病理科
38. 徐国萍 云南省大理学院基础医学院病理教研室
39. 崔丹 辽宁医学院病理教研室
40. 邵云 北京307医院病理科
41. 胡巍 哈尔滨医科大学
42. 付长霞 山东省潍坊市市直机关医院
43. 何诚 福建省肿瘤医院病理科
44. 解正新 安徽省合肥市妇幼保健院病理科
薛德彬（abin）, 赵澄泉（Chengquan Zhao）
于2012年12月12日
原著第一主编Kurman博士
Curriculum Vitae
Robert J. Kurman, M.D.
Revised: 1/29/2013 School of Medicine
Johns Hopkins Hospital
401 North Broadway, Weinberg 2270
Baltimore, Maryland 21231
College:
Queens College, B.A., New York, 1964
Medical School:
Upstate Medical Center,
Syracuse, New York, 1968
Internship:
Medicine and Pathology, Beth Israel Hospital, New York, 1969
Residency and Training:
Pathology, Peter Bent Brigham Hospital, Boston, 1969-70
Pathology, Children’s Hospital and Boston Hospital for Women, Boston, 1970-71
Pathology, Massachusetts General Hospital, Boston, 1971-72
Obstetrics & Gynecology, Boston Hospital for Women, Boston, 1972-73
Obstetrics and Gynecology, Los Angeles County Hospital/University of Southern California,
Los Angeles, 1976-78
Academic and Hospital Appointments:
Clinical Fellow in Obstetrics and Gynecology, Harvard Medical School, Boston, 1972
Assistant Chief, Department of Gynecology and Breast
Pathology, Armed Forces Institute of Pathology, Washington, D.C., 1973-76
Assistant Professor, Pathology, University of Southern California, Los Angeles, 1976-78
Associate Professor, Pathology and Obstetrics and Gynecology, Georgetown University
School of Medicine, Washington, D.C., 1978-82
Associate Professor, with tenure, Pathology and Obstetrics and Gynecology, Georgetown
University School of Medicine, 1983-86
Professor, Pathology and Obstetrics and Gynecology, Georgetown University School of Medicine, 1986-88
Richard W. TeLinde Professor of Gynecologic Pathology, Departments of Gynecology-
Obstetrics and Pathology, The Johns Hopkins University School of Medicine, 1989
Director of Gynecologic Pathology, The Johns Hopkins Hospital, 1989
Richard W. TeLinde Distinguished Professor of Gynecologic Pathology, 1998
Professor of Oncology, The Johns Hopkins University School of Medicine, 2003
Awards:
Phi Beta Kappa, 1964
Presidential Award for Best Scientific Presentation, Society of Gynecologic Oncology, 1985
Recognition Award, International Academy of Pathology, 1987
Presidential Award for the Best Paper, Society of Gynecology Oncology, 1988
National Faculty Award for Excellence in Resident Education in Obstetrics and Gynecology,
1994
Alpha Omega Alpha, 2004
The Fred W. Stewart Award of Memorial Sloan Kettering Cancer Center, 2009
Maude Abbott Lecturer, USCAP meeting, Vancouver, 2012
Consultant:
Visiting Scientist – Armed Forces Institute of Pathology, 1982-1993, Review Panel Pathologist,
Cancer and Steroid Hormone (CASH)CDC-NIH Grant, 1982-84
Consultant – Coordinating Pathologist – Westat – NCI
Contract – Epidemiologic Study of Black/White Differences in Cancer Patient Survival
Experience, 1983-87
Integration Panel Member – Department of Defense Congressionally Directed Medical Research
Program in Ovarian Cancer, 1997-00
Consultant – American Registry of Pathology, 1998
Consultant – Armed Forces Institute of Pathology, 2002
Journal Activities:
Editorial Board, International Journal of Gynecological Pathology, 1982
Editorial Board, Seminars in Diagnostic Pathology, 1983
Editorial Board, Modern Pathology, 1987-2005
Editorial Board, Surgical Pathology, 1988
Editorial Board, Journal of Gynecologic Surgery, 1989
Editorial Board, Gynecologic Oncology, 1992
Editorial Board, Cancer Cytopathology, 1996
Guest Editor, International Journal of Gynecological Pathology, Symposium on
Immunocytochemistry in Gynecological Pathology, 1984
Guest Editor, Seminars in Diagnostic Pathology, Pathology of the Uterine Corpus, 1988
Editorial Board, International Journal of Surgical Pathology, 1993
Editorial Board, Human Pathology, 1999
Editorial Advisory Board, American Journal of Obstetrics and Gynecology, 2006
Reviewer:
Cancer
American Journal of Surgical Pathology
Obstetrics and Gynecology
Journal of Histochemistry and Cytochemistry
Journal of the National Cancer Institute
Archives of Pathology and Laboratory Medicine
Laboratory Investigation
Journal of the American Medical Association
American Journal of Obstetrics and Gynecology
Placenta
American Journal of Pathology
New England Journal of Medicine
Human Pathology
Proceedings of the National Academy of Sciences, USA
International Journal of Cancer
Diplomat and Fellow:
National Board of Medical Examiners, 1969
American Board of Pathology, 1972
American Board of Obstetrics and Gynecology, 1980
American College of Obstetrics and Gynecologists, 1981
Professional Societies:
Washington, D.C., Society of Pathologists, 1974 (President 1986-87)
International Academy of Pathology, 1975
American Society of Clinical Pathologists, 1975
International Society of Gynecologic Pathologists, 1978
Secretary 1998-2003
Vice President 2004-05
President 2006-2007
Medical Society of the District of Columbia, 1979
Society of Gynecologic Oncologists, 1979
Arthur Purdy Stout Society of Surgical Pathologists, 1980
American Medical Association, 1980
New York Academy of Science, 1982
International Gynecologic Cancer Society, 1985
Executive Council, Pathology Representative, 2008
Western Society of Gynecologic Oncology (Honorary Member), 1986
American Society for Colposcopy and Cervical Pathology, Board of Directors, 1990
The Howard A. Kelly Gynecologic and Obstetric Society (Founding member), 1991
Licensure:
New York, #105345, 1969
Washington, D.C., #6781, 1973
Maryland, #D17627, 1975
California, #G35167, 1977
Nevada, #12727, 2008
National Committees:
Member, Pathology Committee, Gynecologic Oncology Group, 1978
Member, Endometrial Cancer Committee, Gynecologic Oncology Group, 1979
Member, Membership Committee, Gynecologic Oncology Group, 1980
Member, Cancer Task Force, American Society of Clinical Pathologists, 1981
Member, Program Committee, Society of Gynecologic Oncology, 1982, 1988
Member, Endometrial Cancer Nomenclature Committee, International Society of Gynecological
Pathologists and WHO, 1983
Chairman, Trophoblastic Disease Nomenclature Committee, International Society of
Gynecological Pathologists and WHO, 1983
Member, Executive Committee, Gynecologic Oncology Group, 1984
Member, Cervical Cancer Nomenclature Committee, International Society of Gynecological
Pathologists, 1987
Member, Task Force on Hysterectomy, American College of Obstetrics and Gynecology, 1988
Member, Committee on Human Research, American College of Obstetrics and Gynecology,
1988-89
Member, Prolog Task Force, American College of Obstetrics and Gynecology, 1988-1990
Member, Working Group, The Bethesda System for classification of cervical and vaginal
cytology, 1988
Chairman, The Second Bethesda System Conference, National Cancer Institute, Bethesda, 1991
Member, Editorial Committee, The Second Bethesda System, 1991
Chairman, Criteria Committee, The Second Bethesda System, 1991
Chairman, Committee for Development of Provisional Guidelines for the Management of
Abnormal Pap Smears, NCI, Bethesda, 1992
Member, Detection & Treatment Advisory Group on Gynecological Cancer, American Cancer
Society, 1993
Member, American Cancer Society Task Force on Gynecologic Cancer, 1993
Member, Detection & Treatment Advisory Group on Gynecological Cancer, American Cancer
Society, 1994
Member, Prolog Task Force, American College of Obstetrics & Gynecology, 1994-1995
Member, Congressionally Directed Medical Research Program, Ovarian Cancer Integration
Panel, 1997-present
Member, Nomenclature Committee, International Society for the Study of Gestational
Trophoblastic Disease, 1999
Member, American Joint Committee on Cancer’s Gynecologic Task Force, 2000
Member, Scientific and Medical Advisory Committee of the Ovarian Cancer and National Alliance, 2006
Member, International Federation of Gynecology and Obstetrics (FICO) Committee, 2006
Hospital and Medical School Committees:
Executive Faculty Committee, Department of Gynecology and Obstetrics, 1989 - to present
Executive Faculty Committee, Department of Pathology, 1989-1993
Visiting Professorships and Endowed Lectures:
University of Virginia, Charlottesville – Thornton Symposium, Keynote Speaker - The 6th Annual
John M. Nokes Lecture, 1984
University of Connecticut Health Center, Feature Speaker at Third Annual Ella T. Grasso
Memorial Conference, 1984
Booth Memorial Hospital First Ancel Blaustein Memorial Lecture, New York, 1985
University of Rochester Medical Center, The Eighth Annual Dr. Jerome H. Rudolph Memorial
Lecture, 1989
University of California, Irvine, The Shirley Nissen Lecture, 1989
Baptist Memorial Hospital, The Merlin L. Trumbull Lectureship in Pathology, Memphis, 1989
Brigham and Womens Hospital, 75th Anniversary Celebration, Distinguished Alumni Pathology
Symposium, 1989
St. Johns Mercy Medical Center, The Fredrick Germuth Memorial Lecture, St. Louis, 1990
Jefferson Medical College, The Warren Lang Memorial Lecture, Philadelphia, 1990
University of Pittsburgh, Magee-Womens Hospital, The Second Annual Aron E. Szulman
Lecture, Pittsburgh, Pennsylvania, 1990
University of Western Ontario, School of Medicine, The Paterson Memorial Lecture, London,
Ontario, 1990
George Washington University, School of Medicine, The Alexander Breslow Memorial Lecture,
Washington, D.C., 1991
University of Michigan, School of Medicine, The First John R.G. Gosling Lecture, Ann Arbor,
1991
University of Minnesota, School of Medicine, Robert O. Meyer, Lectureship in Gynecologic
Pathology, 1991
Albert Einstein College of Medicine, The Fifth Annual Herbert G. Winston Lecture in Obstetrics
and Gynecology of the Raymond and Beverly Sackler Foundation, New York, 1991
Pennsylvania Hospital, The Nineteenth Annual S. Leon Israel Memorial Lecture, Philadelphia,
1991
University of South Florida, Tampa, 1991
California Pacific Medical Center, San Francisco, Koret Visiting Professor, 1992
Tulane University School of Medicine, The Fifth William Sternberg Memorial Lecture, New
Orleans, 1994
Emory University, Atlanta, Georgia, 1996
Stanford University, Stanford, California, 1996
Kaiser Permanente Hospital, San Francisco, California, 1996
The James Platt-White Memorial Lecture, Buffalo Gynecologic and Obstetric Society, Buffalo,
New York, 1996
The University of Iowa, Iowa City, Iowa, 1996
The First Pasman Visiting Professor, Vrije Universiteit, Amsterdam, 1996
University of Graz, Graz, Austria, 1996
University of Vienna, Vienna, Austria, 1998
University of Tel-Aviv, Tel-Aviv, Israel, 1998
The John B. Holyoke Surgical Pathology Lecture, Denver, Colorado, 1998
Wilford Hall Airforce Hospital, San Antonio, Texas, 1999
Rush-Presbyterian – St. Luke’s Medical Center, Chicago, Illinois, 2000
1st Dinh-Doherty-Hannigan Lecture in Gynecologic Pathology, Galveston, Texas, 2000
Alexander P. Papamarkou Lecture, Memorial Sloan-Ketting Cancer Center, NY, NY, 2001
Penrose Hospital, Colorado Springs, Colorado, 2001
Madigan Army Medical Center, Takoma, Washington, 2001
Armed Forces Institute of Pathology, Washington DC, 2002
Jefferson Medical College, The 14th Annual Warren Lang Memorial Lecture, 2002
The Seventh Annual Mathews Distinguished Visiting Professor of Pathology at Emory
University, Atlanta, Georgia, 2002
University of Bologna, Department of Obstetrics and Gynecology, 2004
University of Rome, Department of Pathology, 2004
University of Michigan, Department of Pathology, 2004
University of Basel, 150th Anniversary of the Pathology Institute, Basel, Switzerland, 2005
Yale University School of Medicine, Department of Obstetrics and Gynecology, 2008
Warren Lang Lectureship, Jefferson University School of Medicine, 2008
Lauren Ackerman Memorial Lectureship, Washington University, St. Louis, 2008
Beth Israel and Deaconess Hospital, Harvard Medical School, Boston, Mass, 2009
Rush Presbyterian Medical Center, Chicago, Illinois, 2009
Marmara University, Istanbul, Turkey, 2009
Annual Dr. Marie-Claire Marroum lecture, Charlotte, North Carolina, 2010
University of Iowa, 2010
Distinguished Lecturer, Fox Chase Cancer Center, Philadelphia, PA, 2011
Visiting Faculty – Postgraduate Courses:
Member, Gynecologic Pathology Course, Armed Forces Institute of Pathology, 1973-1994
Director, Workshop on Endocrine Pathology of the Female Genital Tract, American Society of
Clinical Pathology, 1975-79
Member, Workshop on Diagnostic Problems in Gynecologic Pathology, American Society of
Clinical Pathologists, 1976-77
Member, Gynecologic Pathology Specialty Conference, International Academy of Pathology,
1977
Member, Postgraduate Course in Obstetrics and Gynecology, University of Southern California,
Los Angeles, 1978
Member, Gynecologic and Obstetrics Pathology Course, Harvard Medical School, Boston, 1979-
1990
Member, Preinvasive and Early Invasive Tumors of the Female Genitalia, University of
Tennessee, Center for Health Sciences, Memphis, 1979
Moderator, Symposium on Recent Advances in Gynecologic Pathology, Joint Meeting,
Washington, D.C. and Maryland Society of Pathologists, Bethesda, 1979
Member, Testicular Tumor Pathology Panel, Minneapolis, 1980
Member, Gynecologic Pathology Course, American College of Obstetricians and Gynecologists,
Armed Forces District Meeting, Phoenix, 1981
Member, Gynecologic Oncology Course, Georgetown University School of Medicine, 1981-85
Director, Pathology of the Ovary, Short Course, Inter national Academy of Pathology, 1981-86
Member, J. Donald Woodruff Symposium on Gynecologic Oncology, Baltimore, 1982, 1983,
1988, 1989, 1990, 1991
Member, Obstetric and Gynecologic Pathology Course, American College of Obstetrics and
Gynecology, 1982-86
Director, Advances in the Application of Immunocytochemistry in Surgical Pathology, Specialty
Course, International Academy of Pathology, 1983, 1985, 1987
Moderator, Scientific Session, Society of Gynecologic Oncology Meeting, Scottsdale, 1983
Member, Problems in Surgical Pathology, National Institutes of Health, 1983-1991
Member, Selected Topics in Surgical Pathology, Short Course, American Society of Clinical
Pathology, 1984-87
Member, Gynecologic and Obstetrics Pathology Course with Clinical Correlation, University of
Alicante, Spain, 1984
Member, Controversies in Surgical Pathology, American Society of Clinical Pathology, New
Orleans, 1984
Member, Laser Surgery in Gynecology and Hysteroscopy, Columbia Hospital for Women,
Wash., D.C., 1984-1991
Member, Surgical Pathology Review Course, University of Texas, Dallas, 1985
Member, Johns Hopkins Review Course in Reproductive Endocrinology, General Gynecology,
and Gynecologic Oncology, Hilton Head, 1985, 1989
Member, Update in Gynecologic Oncology, St. John’s Hospital, Detroit, 1985
Member, International Society of Gyneoclogical Pathologists’ Symposium on
Immunocytochemistry in Gynecological Pathology, Sendai, Japan, 1986
Member, Kansai Obstetrical and Gynecological Pathology Symposium, Recent Advances in
Gynecological Pathology, Osaka, Japan, 1986
Member, Advanced Gynecologic Oncology, Harvard Medical School, Director, Georgetown
Obstetrics and Gynecology Review Course, 1987, 1988
Member, Comprehensive Update in Obstetrics and Gynecology, Perinatal Resources, New York,
1986, 1987
Member, Symposium-Recent Advances in Sexually Transmitted Diseases, 26th ICAAC Seminar,
New Orleans, 1986.
Member, Obstetrics and Gynecology Review, American College of Obstetrics and Gynecology,
Dublin, Ireland, 1986
Member, Risk Factors and Alternate Treatments in Gynecologic Oncology, Italian Society of
Gynecologic Oncology, Santa Margherita Ligure, Italy, 1986
Member, Gynecological Pathology Review Course, American Society of Clinical Pathology,
Williamsburg, 1987
Member, Laser Surgery and Hysteroscopy in Gynecology Course,Virginia Beach, 1987-1990
Member, Emil Novak Memorial Course, Gynecology, Endocrinology, and High Risk Obstetrics,
Johns Hopkins University, School of Medicine, Baltimore, 1987- 2002
Member, Emerging Technology and Future Trends in Clinical Laboratory Molecular Analysis,
Scripps Clinic and Research Foundation, San Diego, 1988
Director, Short Course, Interpretation of Endometrial Curettings and Biopsies, International
Academy of Pathology, 1988-1992
Member, Update in Surgical Pathology 1988,
Current Topics in Gynecologic Pathology, Washington Hospital Center, 1988
Member, International Symposium - Surgery in the Treatment of Gynecologic Cancer, University
of Antwerp, Antwerp, Belgium, 1988
Member, The Italian Society of Gynecological Oncology and the EORTC-Gynecological Cancer
Cooperative Group – The Conservative Treatment of Gynecological Malignancies, Santa
Margherita Ligure, Italy, 1988
Member, 8th Annual Update in Obstetrics and Gynecology, University of Maryland, Annapolis,
1989
Member, American Society for Colposcopy and Cervical Pathology, Update on HPV Infection of
the Female Genital Tract Symposium, 1989
Member, Annual Postgraduate Review Course in Obstetrics and Gynecology, University of
California, San Francisco, 1989, 1990
Member, Comprehensive Review Course in Obstetrics and Gynecology, Georgetown University
School of Medicine, 1989-present
Member, International Academy of Pathology, Long Course, Pathology of Reproductive Failure,
Boston, 1990
Member, American Association of Pathologists, Symposium on Molecular Carcinogenesis,
Boston, 1990
Member, Fourth International Symposium on Papillomavirus Infection and Genital Neoplasia,
Chicago, 1990
Member, Review Course in Gynecologic Pathology, Magee-Womens Hospital, Pittsburgh, 1990
Member, ACOG-Advances Colposcopy Review Course, Jackson Hole, 1991
Member, 31st Annual Postgraduate Course in A Clinical and Histopathologic Overview of
Obstetrics and Gynecology, New York, 1991 to present
Member, 47th Obstetrical and Gynecological Assembly of Southern California, Los Angeles,
1992
Member, Robert Meyer Symposium, Berlin, Germany, 1992
Member, ACOG-Advanced Colposcopy Review Course, Tucson, 1992
Member, California Society of Pathologists, Annual Meeting, San Francisco, 1992
Member, Orange County Ob/Gyn Symposium, Irvine, 1993
Member, University of Texas, Southwestern Medical Center at Dallas, Current Issues in Surgical
Pathology, XII, 1993
Member, Organizing Committee, 12th International Papillomavirus Conference, Baltimore, 1993
Member, University of Iowa, Second Annual Review Course in Surgical Pathology, 1993
Member, The 4th Annual Review Course on Gynecologic Oncology and Pathology Matsumoto,
Japan, 1993
Member, The Stanford University Current Concepts in Surgical Pathology Course, Stanford,
California, 1994
Member, New York Symposium on Gynecological Cancer, New York, 1996
Member, Panel - Pathology of Incipient Neoplasia and Pathology of the Ovary, XXI International
Congress of the International Academy of Pathology, Budapest, 1996
Co-Chairman, Panel - The Pathology of Pregnancy Related Conditions, XXI International
Congress of the International Academy of Pathology, Budapest, 1996
Member, 17th Annual Nation’s Capital Advanced Gynecologic Surgery, Washington, D.C., 1997
Member, Surgical Pathology Review Course, Johns Hopkins University School of Medicine,
1997 to present
Member, Johns Hopkins-Humboldt University Joint Course in Surgical Pathology, Berlin,
Germany, 1998
Director, Novak Memorial Course in Gynecological Pathology, Gynecology, Endocrinology and
High Risk Obstetrics, Johns Hopkins University School of Medicine, Baltimore, Maryland
1993 – present
Director, Gynecologic Pathology Review Course, Johns Hopkins University School of Medicine,
Baltimore, Maryland 1998 – present
Member, Pathology Education Course, Snowmass, Colorado, 1999
Moderator, International Society of Gynecological Pathologists Symposium on Endometrial
Hyperplasia, New Orleans, 2000
Member, Surgical Pathology in the 21st Century, The University of Texas Southwestern Medical
Center at Dallas, 2000
Co-Moderator – The Bethesda System for Reporting Cervical and Vaginal Cytology, Bethesda,
Maryland 2001
Member, 3rd Joint International Workshop. Histologic and Cytologic Characterization of Human
Tumors:Adjuncts in the Diagnosis, Prognosis and Clinical Monitoring Ischia, Italy, 2001
Member, Ovarian Cancer and High-Risk Women:Implications of Prevention, Screening and
Early Detection, Magee-Womens Hospital, U of Pittsburg, 2002
Member, Fifth Annual UCSF and Stanford Current Issues in Anatomic Pathology, 2002, San
Francisco, 2002
Member, Women’s Cancer:Screening and Prevention, Inova Fairfax Hospital Cancer Center,
Fairfax, 2002
Member, NCI Consensus Meeting on Ovarian Borderline Tumors, Bethesda, 2003
Member, Symposium on Ovarian Borderline Tumors, New Orleans, 2003
Member, California Society of Pathologists, 56th Annual Convention, San Francisco, 2003
Member, University Course – Gynecological Neoplasia and Cancer for Gynecologists, Pathologists, and Doctors in Training, Stavanger, Norway, 2004
President, Multidisciplinary International Conference on Gynecologic Cancer, Bologna, 2005
Moderator, International Society of Gynecologic Pathologists Symposium on Ovarian Borderline Tumors, Atlanta, 2006
Member, Surgical Pathology Evening Specialty Conference, USCAP meeting, Atlanta, 2006
Member, Course in Gynecologic Pathology of the Uterus, Aula Gemelli Instituti Biologici, Rome, 2006
Keynote speaker, 10th Panhellenic Congress of Obstetrics and Gynecology, Patras, Greece, 2006
Member, 1st International Ovarian Cancer Conference, Crete, Greece, 2006
Member, 11th Biennial International Gynecologic Cancer Society Meeting (IGCS): Satellite Symposium on Gynecological Tumor Pathology Honoring Professor Harold Fox, Loews Hotel, Santa Monica, CA, 2006
Moderator, International Society of Gynecologic Pathologists Symposium on Ovarian Cancer, San Diego, 2007
Moderator, Gynecologic Pathology Evening Speciality Conference, USCAP Meeting, 2008-11
Co-Director, Short Course Surface Epithelial Tumors of the Ovary, USCAP Meeting 2008-12
Co-Director, Ovarian Cancer Symposium. Elucidating Early Ovarian Carcinogenesis: Implications for Early Detection and Treatment. JHMI, Baltimore, MD, 2009
Course Faculty, 28th Annual Current Issues in Surgical Pathology, Dallas, Texas, 2009
Member, ASCP Gynecologic Pathology Course, Chicago, IL, 2009
Member, Symposium on Gynecologic Pathology, International Gynecologic Cancer Society, Prague, Czech Republic, 2010
Member, Evening Speciality Conference in Gynecology Pathology, USCAP, San Antonio, Texas, 2011
Member, Course in Gynecologic Pathology, Universita Cattolica del Sacro Cuore, Rome, Italy, 2011
Member, USCAP 2011 Diagnostic Pathology Update, Jackson Hole, WY, 2011
Florida Society of Pathologists, 38th Annual Conference Anatomic Pathology, Orlando, 2012
Invited Speaker:
State University of New York, Stony Brook Medical Center, Stony Brook, 1977
University of Chicago, Chicago, 1978
Pacific Coast Fertility Society, Scottsdale, 1978
Association of Clinical Scientists, Washington, D.C., 1978
International Society of Gynecologic Pathology, San Francisco, 1979
University of South Florida, Tampa, 1979
St. Louis Society of Pathologists, St. Louis, 1979
University of Utah, Salt Lake City, 1979
St. John’s Mercy Medical Center, St. Louis, 1979
Walter Reed Army Medical Center, Washington, D. C., 1980
National Institutes of Health, Bethesda, 1980, 1984
Arthur Purdy Stout Society of Surgical Pathologists, New Orleans, 1980
Howard University School of Medicine, Washington, D.C., 1980
International Symposium on Human Testis Cancer, Mouse Teratocarcinoma and Oncofetal
Proteins, Minneapolis, 1980
International Society of Gynecologic Pathology, Paris, 1980
George Washington University School of Medicine, Washington, D.C., 1981
Seattle Gynecological Society, Seattle, 1981
University of Pittsburgh, 1981
Madigan General Hospital, Tacoma, Washington, 1981
University of Washington, Seattle, 1981
Beth Israel Hospital, New York, 1982
Washington, D.C. Cytology Society, 1983
The Minnesota Obstetrical and Gynecological Society, Minneapolis, 1983
International Symposium of Gynecologic Pathology, Heidelberg, 1983
European Congress of Pathology, Hamburg, 1983
New York Pathology Society, 1984
International Society of Gynecological Pathologists, San Francisco, 1984
Tripler Army Hospital, Hawaii, 1984
American Academy of Dermatology, Washington, D.C., 1984
American Society of Microbiology, Symposium on Papillomaviruses, Las Vegas, 1985
UCLA Symposium on Molecular and Clinical Aspects, Plenary Speaker, Steamboat Springs,
1985
International Federation of Gynecologists and Obstetricians, West Berlin (FIGO), 1985
University of Cincinnati, 1985
Western Association of Gynecologic Oncologists, Keynote Speaker, Monterey, 1986
Colorado State Societies of Pathology and Obstetrics and Gynecology, Breckenridge, 1986
International Workshop on Papillomaviruses, Director of Workshop on Pathology for Molecular
Biologists, Cold Spring Harbor, 1986
Interferon Therapy for Human Papillomaviruses Diseases Investigators Meeting, Research
Triangle Park, 1986
Seventeenth Annual Seminar of the Nassau and Suffolk County Society of Pathologists, Special
Guest Speaker, Gynecologic Pathology Slide Seminar, New York, 1986
ICAAC Symposium on Recent Advances in Sexually Transmitted Diseases, New Orleans, 1986
Yale University School of Medicine, New Haven, 1986
International Society of Gynecological Pathologists, Chicago, 1987
Texas A & M, 1987
Michael Reese Hospital, Chicago, 1987
Communitech, Cancer Progress II, New York, 1987
Veterans Administration Hospital, Washington, D.C., 1987
Felix Rutledge Society, Guest Speaker, Houston, 1987
University of California, San Francisco, Guest Speaker at Postgraduate Course, Current Issues in
Anatomic Pathology, 1987
New York University Medical Center, Obstetrical and Gynecological Society, New York, 1987
Los Angeles Obstetrical and Gynecological Society, Los Angeles, 1987
The California Tumor Tissue Registry, 84th Semi-Annual Cancer Seminar on Gynecological
Pathology, San Francisco, 1987
Society of Gynecologic Investigation, Baltimore, 1988
Downstate Medical Center, New York, 1988
University of Rochester, School of Medicine, 1988
University of Tennessee, School of Medicine, 1988
New Jersey Society of Pathologists, New Jersey, 1989
University of Maryland, 1989
Bringham and Women’s Hospital, 75th Anniversary Celebration, Distinguished Alumni Pathology
Symposium, 1989
Orange County Obstetrics and Gynecology Society, 1989
Long Beach Memorial Medical Center, 1989
The Memphis Society of Pathologists, 1989
St. Agnes Hospital, 1989
Maryland General Hospital, 1990
Franklin Square Hospital, 1990
National Taiwan University, Taiwan, 1990
Society of Gynecologic Investigation, St. Louis, 1990
Women’s and Brigham Hospital, Boston, 1990
Memorial Sloan-Kettering Cancer Center, New York, 1990
Boston Obstetrical Society, Boston, 1991
International Society of Gynecological Pathologists, Chicago, 1991
American College of Obstetricians and Gynecologists, New Orleans, 1991
University of Pennsylvania, Philadelphia, 1991
German Society for Pathology, Friedrichshafen, Germany, 1991
University of Freiburg, Freiburg, Germany, 1991
Emory University, Atlanta, 1991
International Papillomavirus Meeting, Seattle, 1991, Plenary Speaker
Tampa Obstetrics and Gynecology Society, 1991
Washington Hospital Center, Washington, D.C., 1992
Greater Baltimore Medical Center, Baltimore, 1992
New York State Society of Pathologists, Tarrytown, New York, 1992
Freie University of Berlin, Germany, 1992
Washington Gynecological Society, Washington, D.C., 1992
San Francisco Gynecological Society, San Francisco, 1993
University of California, San Francisco, 1993
Stanford University, Palo Alto, 1993
American College of Obstetrics and Gynecology, Annual Meeting, Washington, D.C., 1993
American Society of Colposcopy and Cervical Pathology, Chicago, 1993
Yale University School of Medicine, New Haven, 1993
31st Annual Congress, Japanese Cancer Society for Cancer Treatment Meeting, Osaka, Japan,
1993
2nd Robert Meyer Memorial Symposium. International Society of Gynecological Pathologists
and the German Division of The International Academy of Pathology. Recent Advances in the
Pathology of Gynecologic Tumors made Possible by Molecular Biology. Weimar, Germany,
1994
Georgetown University, School of Medicine, Pathology, Grand Rounds, Washington, D.C., 1994
Connecticut Society of Pathologists, Farmington, Connecticut, 1995
Boston Obstetrical Society, Boston, Massachusetts, 1995
Tufts New England Medical Center, Boston, Massachusetts, 1995
New York Obstetrical Society, New York, New York, 1995
12th Annual Ella T. Grasso Symposium, New Haven, Conn., 1995
New Haven Obstetrical Society, New Haven, Conn., 1995
San Francisco Gynecological Society, San Francisco, California, 1996
Stanford University, Stanford, California, 1996
Georgetown University, Washington, D.C., 1996
Buffalo City Wide Ob/Gyn Grand Rounds, Buffalo, New York, 1996
Washington Society of Pathologists, Bethesda, Maryland, 1996
New York Pathological Society, Symposium on Gynecologic Cancer, 1996
Dept. Obstetrics & Gynecology, The Massachusetts General Hospital, Boston, Massachusetts,
1996
Symposium in Progress in Diagnosis and Treatment of Gynecological (Pre) malignancies, Vrije
Universiteit Hospital, Amsterdam, 1996
Plenary Speaker, Austrian Society of Pathologists, Vienna, Austria, 1998
The South Bay Pathology Society, 47th Annual Spring Meeting, Monterey, California, 1998
University of Maryland Medical School, Baltimore, Maryland, 1998
12th Annual Symposium on the Long-Term Effects of Estrogen Deprivation, Los Cabos, Baja,
California, 1998
IX World Congress on Gestational Trophoblastic Diseases, Jerusalem, Israel, 1998
American College of Obstetrics and Gynecology, Armed Forces District Meeting, San Antonio,
Texas, 1999
XXVI International Symposium on Gynecologic Oncology, Barcelona, Spain, 1999
Yale University, School of Medicine, New Haven, 2000
Tri-State Pathology Society Meeting, New Orleans, Louisiana, 2000
Second Joint International Workshop. Histologic and Cytologic Characterization of Human
Tumors: Borderline Neoplasia, Capri, Italy, 2000
The Austrian Society of Pathology, Vienna, Austria, 2000
University of South Florida, Tampa, 2000
Florida West Coast Association of Pathologists, Tampa, 2000
Michigan Society of Pathologists, Detroit, 2000
Michigan International Society of Gynecologic Pathologists, Atlanta, 2001
Australian Society of Colposcopy and Cervical Pathology, Perth, Australia, 2001
American Registry of Pathology, 25th Anniversary Scientific Symposium, Wash, D.C., 2001
Keynote Speaker, Pathological Society of Great Britain and Ireland, Liverpool, U.K., 2001
International Papillomavirus Conference, Florianopolis, Brazil, 2001
European Congress of Pathology, Berlin, Germany 2001
Dana-Farber/Harvard Cancer Center, Ovarian Cancer Symposium, Boston, 2001
Georgetown University School of Medicine, Wash DC, 2002
4th Biennial Ovarian Cancer Research Symposium, Swedish Medical Center, Seattle, 2002
Washington State Society of Pathologists, Skamania, Oregon, 2002
Phoenix Ob/Gyn Society, Phoenix 2003
Armed Forces Institute of Pathology, Washington DC, 2003
The National Cancer Institute “Regina Elena”, Rome Italy, 2003
Australian Division of the International Academy of Pathology, 29th Annual Scientific Meeting,
Sydney, Australia 2003
The San Antonio Society of Pathologists, 60th Annual Meeting, San Antonio 2004
The 9th Panhellenic Congess of Pathology, Kavala, Greece 2004
Los Angeles Society of Pathologists, George Kypridakis Memorial Lecture, 2004
Arthur Purdy Stout Society of Pathologist, San Antonio, 2005
The Fifth Panhellenic Congress on Gynecological Oncology, Athens, 2005
The Panhellenic Gynecologic Oncology Congress, Athens, 2005
The Croatian Society of Cytopathologists and Pathologists, Opatija, Croatia, 2005
Grand Rounds, Weil Medical College-Cornell University, New York, 2005
Grand Rounds, Georgetown University School of Medicine, Washington, D.C., 2006
Grand Rounds, New York University School of Medicine, New York, 2006
Keynote Speaker, Austrian Society for Pathology, Graz, Austria, 2006
South Bay Society of Pathologists, Slide Seminar, Monterey, California, 2007
Ob/Gyn Seminar sponsored by Quest Laboratories, Las Vegas, 2007
Keynote Speaker, Pacific Northwest Society of Pathologists, Portland, Oregon, 2007
Keynote Speaker, 4th Annual Meeting of the British Association of Gynaecological Pathologists, London, 2007
Colorado Society of Clinical Pathologists, Fourth Annual Stars in the Mountains Pathology Seminar, Vail, Colorado, 2007
Sacro Cuore-Don Calabria Hospital, Negrar-Verona, Italy, 2008
European Oncology Institute, Milan, Italy, 2008
St. Louis Society of Pathologists, 2008
American Society of Clinical Pathology, Baltimore, 2008
International Gynecologic Cancer Society, Bangkok, Thailand, 2008
7th Korea-Japan Gynecologic Cancer Joint Meeting, Seoul, Korea, 2008
American Association of Cancer Research, Symposium on Ovarian Cancer, Denver, 2009
The New England Pathology Society, Boston, 2009
The Shields Warren Lecture, 2009
The New England Pathology Society, 2009
Turkish Federation of Pathologists, Northern Republic of Cyprus, 2009
Helene Harris Memorial Trust 12th international Forum on Ovarian Cancer, Miami, Florida 2011
Keynote Speaker, Joint Annual Meeting, Swiss and Austrian Societies of Pathology, Feldkirch, Austria, 2010
Keynote Speaker, Wayne State University, Annual Gynecologic Oncology and Gynecologic Pathology Symposium, Detroit, 2011
University of Brescia, Brescia, Italy 2011
4th European Symposium on Ovarian Cancer, Reims, France, 2011
Keynote Speaker 61st New Jersey Society of Pathologists, Woodbridge, NJ, 2011
Publications:
Original Reports:
1. Ober WB, Sobrero AJ, Kurman RJ and Gold S: Endometrial morphology and polyethylene intrauterine devices. A study of 200 endometrial biopsies. Obstet Gynecol 1968; 32:7882-793.
2. Kurman RJ, Funk RL and Kirshenbaum AH: Spina bifida associated choristoma of mullerian origin. J Pathol 1968; 99:324-327.
3. Kurman RJ and Craig JM: Endometrioid and clear-cell carcinoma of the ovary. Cancer 1972; 29:1653-1664.
4. Herbst AL, Kurman RJ and Scully RE: Vaginal and cervical abnormalities after exposure stilbestrol in utero. Obstet Gynecol 1972; 40:287-298.
5. Herbst AL, Kurman RJ, Scully RE and Poskanzer DC: Clear cell adenocarcinoma of the genital tract in young females. Registry report. N Eng J Med 1972; 287(25):1259-1264.
6. Kurman RJ and Prabha AC: Thyroid and parathyroid glands in the vaginal wall. Am J Clin Pathol 1973; 59:503-507.
7. Kurman RJ and Scully RE: The incidence and histogenesis of vaginal adenosis. An autopsy study. Human Pathol 1974; 5:265-276.
8. Kurman RJ and Scully RE: Clear cell carcinoma of the endometrium. An analysis of 21 cases. Cancer 1976; 37:872-882.
9. Kurman RJ and Norris HJ: Mesenchymal tumors of the uterus. VI Epithelioid smooth muscle tumors including leiomyoblastoma and clear cell leiomyoma. A clinical and pathologic analysis of 26 cases. Cancer 1976; 37:1853-1865.
10. Leman MH, Benson WL, Kurman RJ and Park RC: Microinvasive carcinoma of the cervix. Obstet Gynecol 1976; 48:571-578.
11. Kurman RJ, Scully RE and Norris HJ: Trophoblastic pseudotumor of the uterus. An exaggerated form of “syncytial endometritis” simulating a malignant tumor. Cancer 1976; 38:1214-1226.
12. Kurman RJ and Norris HJ: Endodermal sinus tumor of the ovary. A clinical and pathologic analysis of 71 cases. Cancer 1976; 38:2404-2419.
13. Kurman RJ and Norris HJ: Embryonal carcinoma of the ovary. A clinicopathologic entity distinct from endodermal sinus tumor resembling embryonal carcinoma of the adult testis. Cancer 1976; 38:2420-2433.
14. Kurman RJ and Norris HJ: Malignant mixed germ cell tumors of the ovary. A clinical and pathologic analysis of 30 cases. Obstet Gynecol 1976; 48:579-589.
15. Kurman RJ, Scardino PT, McIntire KR, Waldmann TA and Javadpour N: Cellular localization of alpha-fetoprotein and human chorionic gonadotropin in germ cell tumors of the testis using an indirect immunoperoxidase technique. A new approach to classification utilizing tumor markers. Cancer 1977; 40:2135-2151.
16. Mack GR, Robey DB and Kurman RJ: Chondrosarcoma secreting chorionic gonadotropin. Report of a case. J Bone and Joint Surg 1977; 59-A:1107-1111.
17. Kurman RJ, Andrade D, Goebelsmann U and Taylor CR: An immunohistological study of steroid localization in Sertoli-Leydig tumors of ovary and testis. Cancer 1978; 42:1772-1783.
18. Taylor CR, Kurman RJ and Warner NE: The potential value of immunohistologic techniques in the classification of ovarian and testicular tumors. Human Pathol 1978; 9:417-427.
19. Kurman RJ, Goebelsmann U and Taylor CR: Steroid localization in granulosa theca tumors of the ovary. Cancer 1979; 43:2377-2384.
20. Baranetsky NJ, Zipser RD, Goebelsmann U, Kurman RJ, March CM, Morimoto I and Stanczyk RA: Adrenocorticotropin dependent virilizing paraovarian tumors in Nelson’s syndrome. J Clin Endocrinol Metab 1979; 49:381-386.
21. Taylor CR, Cooper Cl, Kurman RJ, Goebelsmann U and Markland FS Jr.: Detection of estrogen receptors in breast and endometrial carcinoma by the immunoperoxidase technique. Cancer 1981; 47:2634-2640.
22. Kurman RJ, Shah KH, Lancaster WD, Jenson AB: Immunoperoxidase localization of papillomavirus antigens in cervical dysplasia and vulvar condylomas. Am J Obstet Gynecol 1981; 140:931.
23. Kurman RJ and Norris HJ: Evaluation of criteria for distinguishing atypical endometrial hyperplasia from well differentiated carcinoma. Cancer 1982; 49:2547-2559.
24. Kurman RJ, Sanz LE, Jenson AB, Perry S, Lancaster WD: Papillomavirus infection of the cervix I. Correlation of histology with viral structural antigens and DNA sequences. Int J of Gynecol Pathol 1982; 1:17-28.
25. Kurman RJ, Jenson AB, Lancaster WD: Papillomavirus infection of the cervix II. Relationship to intraepithelial neoplasia based on the presence of specific viral structural proteins. Am J Surg Pathol 1983; 7:39-52.
26. Colgan TJ, Norris HJ, Foster W, Kurman RJ, Fox CH: Predicting the outcome of endometrial hyperplasia by quantitative analysis of nuclear features using a linear discriminant function. Int J Gynecol Pathol 1983; 1:347-352.
27. Lancaster WD, Kurman RJ, Sanz LE, Perry S, Jenson AB: Human papillomavirus: Detection of viral DNA sequences and evidence for molecular heterogeneity in metaplasias and dysplasias of the uterine cervix. Intervirology 1983; 20:202-121.
28. Goes JS Jr., Lemos LB, Jenson AB, Lancaster WD, Kurman RJ: Presence of papillomavirus antigens in premalignant lesions of the uterine cervix in Brazil. Rev Brasil Ginec Obstetr 1983; 35:46.
29. Warhol JJ, Pincus GS, Rice RH, El-Tawil GH, Lancaster WD, Jenson AB, Kurman RJ: Papillomavirus infection of the cervix III. Relationship of the presence of viral structural proteins to the expression of involucrin. Int J Gynecol Pathol 1984; 3:71-81.
30. Kurman RJ, Young RH, Main CS, Lawrence WD, Norris HJ, Scully RE: Immunocytochemical localization of placental lactogen and chorionic gonadotrophin in the normal placenta and trophoblastic tumors with emphasis on intermediate trophoblast and the placental site trophoblastic tumor. Int J Gynecol Pathol 1984; 3:101-102.
31. Huang S-C, Chen H-C, Kurman RJ, Yang Y-S, Wen H-K, Hsieh C-Y, Wei P-Y, How S-W, Chen T-Y, Ouyangs P-C: Secretion of human chorionic gonadotropin and alpha-fetoprotein by an ovarian germ cell tumor of apparent yolk sac origin. Gynecol Oncol 1984; 18:240-246.
32. Kurman RJ, Main CS, Chen H-C: Intermediate trophoblast. A distinctive form of trophoblast with specific morphological, biochemical and functional features. Placenta 1984; 5(4):349-369.
33. Kurman RJ, Kaminski PF, Norris HJ: The behavior of endometrial hyperplasia. A long term study of “untreated hyperplasia in 170 patients. Cancer 1985; 56:403-412.
34. Klappenbach RS, Kurman RJ, Sinclair CF, James LP: Composite carcinoma-carcinoid tumors of the gastrointestinal tract. A morphologic, histochemical and immunocytochemical study. Am J Clin Pathol 1985; 84(2):137-143.
35. Gorra J, Lancaster WD, Kurman RJ, Jenson AB: Bovine papillomavirus type I monoclonal antibodies. JNCI 1985; 75:121-125.
36. Tracy SL, Askin FB, Reddick RL, Jackson B, and Kurman RJ: Progesterone secreting Sertoli cell tumor of the ovary. Gynecol Oncol 1985; 22:85-96.
37. Lancaster WD, Castellano C, Santos C, Delgado G, Kurman RJ, Jenson AB: Human papillomavirus deoxyribonucleic acid in cervical cancer from primary and metastatic sites. Am J Obstet Gynecol 1986; 154:115-119.
38. Rando RF, Sedlacek TV, Hunt J, Jenson AB, Kurman RJ, Lancaster WD: A verrucous carcinoma of the vulva associated with an unusual type 6 human papillomavirus. Obstet Gynecol 1986; 67:70S.
39. Lorincz AT, Temple GF, Patterson JA, Jenson AB, Kurman RJ, Lancaster WD: Correlation of cellular atypia and human papillomavirus DNA sequences in exfoliated cells of the uterine cervix. Obstet Gynecol 1986; 68:508-512.
40. Brescia RJ, Kurman RJ, Main C, Surti U, Szulman AE: The immunocytochemical localization of human chorionic gonadotropin, human placental lactogen, and placental alkaline phosphatase in complete and partial moles. Int J Gynecol Pathol 1987; 6:213-229.
41. Lorincz AT, Temple GF, Kurman RJ, Jenson AB, Lancaster WD: The oncogenic association of specific HPV types with cervical neoplasia. JNCI 1987; 79:671-677.
42. Schiffman MH, Haley NJ, Felton JS, Andrews AW, Kaslow RA, Lancaster WD, Kurman RJ, Brinton LA, Lannom LB, Hoffman D: Biochemical epidemiology of cervical neoplasia: Measuring cigarette smoke constituents in the cervix. Cancer Res 1987; 47:3886-3888.
43. Barnes WA, Delgado G, Kurman RJ, Petrilli E, Smith D, Ahmed S, Lorincz AT, Temple GF, Jenson AB, Lancaster WD: Possible prognostic significance of HPV type in cervical cancer. Gynecol Oncol 1988; 29:267-273.
44. Kurman RJ, Schiffman MH, Lancaster WD, Reid R, Jenson AB, Temple GF, Lorincz AT: Analysis of individual human papillomavirus types in cervical neoplasia. A possible role for type 18 in rapid progression. Am J Obstet Gynecol 1988; 159:293-296.
45. O’Connor DM, Kurman RJ: Intermediate trophoblast in uterine curettings in the diagnosis of ectopic pregnancy. Obstet Gynecol 1988; 72:665-670.
46. Willett GD, Kurman RJ, Reid R, Greenberg M, Jenson AB, Lorincz AT: Correlation of the histologic appearance of intraepithelial neoplasia of the cervix with human papillomavirus types: Emphasis on low grade lesions including so-called flat condyloma. Int J Gynecol Pathol 1989; 8:18-25.
47. Yeh I-T, O’Connor DM, Kurman RJ: Vacuolated cytotrophoblast: A sub-population of trophoblast in the chorion laeve. Placenta 1989; 10:429-438.
48. Morrow CP, Bundy BN, Homesley HD, Creasman WT, Hornback NB, Kurman RJ, Thigpen JT: Doxorubicin as an adjuvant following surgery and radiation therapy in patients with high-risk endometrial carcinoma, stage I and occult stage II: A gynecologic oncology group study. Gynecol Oncol 1990; 36:166-171.
49. Bitterman P, Chun B, Kurman RJ: The significance of epithelial differentiation in mixed mesodermal tumors of the uterus. A clinicopathologic and immunohistochemical study. Am J Surg Pathol 1990; 14:317-328.
50. Yeh I-T, O’Connor DM, Kurman RJ: Intermediate trophoblast: Further immunocytochemical characterization. Mod Pathol 1990; 3:282-287.
51. Young RH, Kurman RJ, Scully RE: Placental site nodules and plaques. Am J Surg Pathol 1990; 14:1001-1009.
52. Negrini BP, Schiffman MH, Kurman RJ, Barnes W, Lannom L, Malley Y, Brinton LA, Delgado G, Jones S, Tchabo J-G, Lancaster WD: Oral contraceptive use, human papillomavirus infection, and risk of early cytological abnormalities of the cervix. Cancer Res 1990; 50:4670-4675.
53. Potkul RK, Lancaster WD, Kurman RJ, Lewandowski G, Week PK, Delgado G: Vulvar condylomas and squamous vestibular micropapilloma. Differences in appearance and response to treatment. J Reprod Med 1990; 35:1019-1022.
54. Park JP, Kurman RJ, Kessis TD, Shah KV: Comparison of peroxidase-labeled DNA probes with radioactive RNA probes for detection of human papillomaviruses by in situ hybridization in paraffin sections. Mod Pathol 1991;4:81-85.
55. Tyler CW Jr, Lee NC, Robboy SJ, Kurman RJ, Paris AL, Wingo PA, Williamson GD: The diagnosis of ovarian cancer by pathologists: How often do diagnoses by contributing pathologists agree with a panel of gynecologic pathologists? Am J Obstet Gynecol 1991; 164:65-70.
56. Park JS, Jones RW, McLean MR, Currie JL, Woodruff JD, Shah KV, Kurman, RJ: Possible etiologic heterogeneity of vulvar intraepithelial neoplasia. A correlation of pathologic characteristics with human papillomavirus detection by in situ hybridization and polymerase chain reaction. Cancer 1991; 67:1599-1607.
57. Toki T, Kurman RJ, Park JS, Kessis T, Daniel RW, Shah KV: Probable nonpapillomavirus etiology of squamous cell carcinoma of the vulva in older women: A clinicopathologic study using in situ hybridization and polymerase chain reaction. Int J Gynec Pathol 1991; 10:107-125.
58. Jones CJ, Schiffman MH, Kurman RJ, Jacob P III, Benowitz NL: Elevated nicotine levels in cervical lavages from passive smokers. Am J Public Health 1991; 81:378-79.
59. Morrow CP, Bundy BN, Kurman RJ, Creasman WT, Heller P, Homesley HD, Graham JE: Relationship between surgical-pathological risk factors and outcome in clinical stage I and II carcinoma of the endometrium. A Gynecologic Oncology Group Study. Gynecol Oncol 1991; 40:55-65.
60. Wu T-C, Mann RB, Epstein JI, MacMahon E, Lee WA, Charache P, Hayward SD, Kurman RJ, Hayward GS, Ambinder RF: Abundant expression of EBER 1 small nuclear RNA in nasopharyngeal carcinoma. A morphologically distinctive target for detection of Epstein-Barr virus in formalin-fixed paraffin-embedded carcinoma specimens. Am J Pathol 1991; 138:1461-1469.
61. Ambros RA, Park J-S, Shah KV, Kurman RJ: Evaluation of histologic, morphometric, and immunohistochemical criteria in the differential diagnosis of small cell carcinomas of the cervix with particular reference to human papillomavirus types 16 and 18. Mod Pathol 1991; 4:586-593.
62. Zaino RJ, Kurman RJ, Herbold D, Gleidman J, Bundy BN, Voet R, Advani H: The significance of squamous differentiation in endometrial carcinoma. Data from a Gynecologic Oncology Group Study. Cancer 1991; 68:2293-2302.
63. Park JS, Rader JS, Wu TC, Laimins LA, Currie, JL, Kurman RJ, Shah, KV: HPV-16 viral transcripts in vulvar neoplasia: Preliminary studies. Gynecol Oncol 1991;42:250-255.
64. Lorincz AT, Reid R, Jenson AB, Greenberg MD, Lancaster WD, Kurman RJ: Human papillomavirus infection of the cervix: Relative risk associations of 15 common anogenital types. Obstet Gynecol 1992; 79:328-337.
65. Ambros RA, Kurman RJ: Combined assessment of vascular and myometrial invasion as a model to predict prognosis in Stage I endometrioid adenocarcinoma of the uterine corpus. Cancer 1992; 69:1424-1431.
66. Sturgeon SR, Brinton LA, Devesa SS, Kurman RJ: In situ and invasive vulvar cancer incidence trends (1973 to 1987). Am J Obstet Gynecol 1992; 166(5):1482-1485.
67. Sherman ME, Bitterman P, Rosenshein NB, Delgado G, Kurman RJ: Uterine serous carcinoma. A morphologically diverse neoplasm with unifying clincopathologic features. Am J Surg Pathol 1992; 16:600-610.
68. Ambros A, Kurman RJ: Identification of patients with stage I uterine endometrial adenocarcinoma at high risk of recurrence by DNA ploidy, myometrial invasion, and vascular invasion. Gynecol Oncol 1992; 45:235-239.
69. Chapman WB, Lorincz AT, Willett GD, Wright VC, Kurman RJ: Epidermal growth factor expression and the presence of human papillomavirus in cervical squamous intraepithelial lesions. Int J Gynecol Pathol 1992; 11:221-226.
70. Sherman ME, Schiffman MH, Erozan YS, Wacholder S, Kurman RJ: The Bethesda System. A Proposal for Reporting Abnormal Cervical Smears Based on the Reproducibility of Cytopathologic Diagnoses. Arch Pathol Lab Med 1992;116:1155-1158.
71. Jones MW, Silverberg SG, Kurman RJ: Well-differentiated villoglandular adenocarcinoma of the uterine cervix: A clinicopathological study of 24 cases. Int J Gynecol Pathol 1993;12:1-7.
72. Chapman WB, Lorincz AT, Willett GD, Wright VC, Kurman RJ: Evaluation of two commercially available in situ hybridization kits for detection of human papillomavirus DNA in cervical biopsies: Comparison to Southern Blot hybridization. Mod Pathol 6:73-79, 1993.
73. Kurman RJ, Toki T, Schiffman MH: Basaloid and warty carcinomas of the vulva:Distinctive types of squamous cell carcinoma frequently associated with human papillomaviruses. Am J Surg Pathol 1993;17:133-145.
74. Laxman R, Currie JL, Kurman RJ, Dudzinski M, Griffin C: Cytogenetic profile of uterine sarcomas. Cancer 1993;71:1283-1288.
75. Sherman ME, Weinstein M, Sughayer M, Cappellari JO, Orr JE, Erozan YS, Schiffman MH, Kurman RJ: The Bethesa System:Impact on reporting cervicovaginal specimens and reproducibility of criteria for assessing endocervical sampling. Acta Ctyologica 1993; 37:55-60.
76. Sheth S, Hamper UM, Kurman RJ: Thickened endometrium in the postmenopausal woman: Sonographic-pathologic correlation. Radiology 1993;187:135-139.
77. Schiffman MH, Bauer HM, Hoover RN, Glass AG, Cadell DM, Rush BB, Scott DR, Sherman ME, Kurman RJ, Wacholder S, Stanton CK, Manos MM: Epidemiologic evidence showing that human papillomavirus infection causes most cervical intraepithelial neoplasia. J Natl Cancer Inst 1993; 85:958-964.
78. Hamper UM, Sheth S, Abbas FM, Rosenshein NB, Aronson D, Kurman RJ: Transvaginal color doppler sonography of adnexal masses: Differences in blood flow impedance in benign and malignant lesions. AJR 1993;160:1225-1228.
79. Hunter CP, Redmond CK, Chen VW, Austin DF, Greenberg RS, Correa P, Muss HB, Forman MR, Wesley MN, Blacklow RS, Kurman RJ, Dignam JJ, Edwards BK, Shapiro S, et al: Breast cancer: Factors associated with stage at diagnosis in black and white women. J Natl Cancer Inst 1993;85:1129-1137.
80. Ambros RA, Kurman RJ: Association of ulex europaeus agglutinin I binding with invasion in endometrial carcinoma. Int J Gynec Path 1993;12:301-306.
81. Bauer HM, Hildesheim A, Schiffman MH, Glass AG, Rush BB, Scott D, Cadell DM, Kurman RJ, Manos MM: Determinants of genital human papillomavirus infection in low-risk women in Portland, Oregon. Sexually Transmitted Diseases 1993;20:274-278
82. Hildesheim A, Gravitt P, Schiffman MH, Kurman RJ, Barnes W, Jones S, Tchabo J-G, Brinton LA, Copeland C, Epp J, Manoe MM: Determinants of genital human papillomavirus infection in low-income women in Washington, D.C. Sexually Transmitted Diseases 1993;20:279-285.
83. Hildesheim A, Schiffman MH, Gravitt PE, Glass AG, Greer CE, Zhang T, Scott DR, Rush BB, Lawler P, Sherman ME, Kurman RJ, Manos MM: Persistence of type-specific human papillomavirus infection among cytologically normal women. J Infect Diseases 1994; 169:235-240.
84. Chen VW, Correa P, Kurman RJ, Wu X-C, Eley JW, Austin D, Muss H, Hunter CP, Redmond C, Herman AA, Edwards BK: Histological characteristics of breast carcinoma in Blacks and Whites. Cancer Epidemiology, Biomarkers & Prevention 1994;3:127-135.
85. Sherman ME, Schiffman MH, Lorincz AT, Manos MM, Scott DR, Kurman RJ, Kiviat NB, Stoler M, Glss AG, Rush BB: Toward objective quality assurance in cervical cytopathology. Correlation of cytopathologic diagnoses with detection of high-risk human papillomavirus types. Am J Clin Pathol 1994;102:182-187.
86. Zaino RJ, Kurman RJ, Diana KL, Morrow CP: The utility of the revised International Federation of Gynecology and Obstetrics histologic grading of endometrial adenocarcinoma using a defined nuclear grading system. Cancer 1995;75:81-6.
87. Hameed A, Fox WM, Kurman RJ, Hruban RH, Podack ER: Perforin expression in endometrium during the menstrual cycle. Int J Gynecol Pathol 1995;14:143-150.
88. Hameed A, Fox WM, Kurman RJ, Hruban RH, Podack ER: Perforin expression in human cell-mediated lutolysis. Int J Gynecol Pathol 1995;14:151-157.
89. Cox JT, Lorincz AT, Schiffman MH, Sherman ME, Cullen A, Kurman RJ: Human papillomavirus testing by hybrid capture appears to be useful in triaging women with a cytologic diagnosis of atypical squamous cells of undetermined significance. Am J Obstet Gynecol 1995;172:946-954.
90. Ronnett BM, Kurman RJ, Zahn CM, Shmookler BM, Jablonski KA, Kass ME, Sugarbaker PH: Pseudomyxoma peritonei in women: A clinicopathologic analysis of 30 cases with emphasis on site of origin, prognosis, and relationship to ovarian mucinous tumors of low malignant potential. Hum Pathol 1995;26:509-524.
91. Sheth S, Hamper UM, McCollum ME, Caskey CI, Rosenshein NB, Kurman RJ: Endometrial blood flow analysis in postmenopausal women: Can it help differentiate benign from malignant causes of endometrial thickening? Radiology 1995;195:661-665.
92. Bosch FX, Manos MM, Munoz N, Sherman M, Jansen AM, Peto J, Schiffman MH, Moreno V, Kurman RJ, Shah KV: Prevalence of human papillomavirus in cervical cancer: A worldwide perspective. J Natl Cancer Inst 1995;87:796-802.
93. Wu T-C, Ling ZY, Kanayama MD, Huang ACY, Kurman RJ: Localization of Epstein-Barr Virus-Encoded small RNA-1 by in situ reverse transcription: Demonstration of cDNA generation in formalin-fixed paraffin-embedded tissue sections. J Biomed Sci 1995;2:249-255.
94. Ambros RA, Sherman ME, Zahn CM, Bitterman P, Kurman RJ: Endometrial intraepithelial carcinoma: A distinctive lesion specifically associated with tumors displaying serous differentiation. Hum Pathol 1995; 26:1260-1267.
95. Sherman ME, Bur ME, Kurman RJ: p53 in endometrial cancer and its putative precursors:evidence for diverse pathways of tumorigenesis. Hum Pathol 1995; 26:1268-1274.
96. Sherman ME, Sturgeon S, Brinton L, Kurman RJ. Endometrial cancer chemoprevention:Implications of diverse pathways of carcinogenesis. J Cell Biochem 1995; 23:160-164.
97. Ronnett BM, Zahn CM, Kurman RJ, Kass ME, Sugarbaker PH, Shmookler BM: Disseminated peritoneal adenomucinosis and peritoneal mucinous carcinomatosis. Am J Surg Pathol 1995;19(12):1390-1408.
98. Barnhill DR, Kurman RJ, Brady MF, Omura Ga, Yordan E, Given FT, Kucera PR, Roman LD: Preliminary analysis of the behavior of Stage I ovarian serous tumors of low malignant potential: A Gynecologic Oncology Group Study. J Clin Oncol 1995; 13(11):2752-2756.
99. Wideroff L, Schiffman MH, Nonnenmacher B, Hubbert N, Kirnbauer R, Greer CE, Lowy D, Lorincz AT, Manos MM, Glass AG, Scott DR, Sherman ME, Kurman RJ, Buckland J, Tarone RE, Schiller J. Evaluation of Seroreactivity to human papillomavirus type 16 virus-like particles in an incident case: Control study of cervical neoplasia. J Infect Dis 1995; 172(6):1425-1430.
100. Trimble CL, Hildesheim A, Brinton LA, Shah KV, Kurman RJ: Heterogeneous etiology of squamous carcinoma of the vulva. Obstet Gynecol 1996; 87:59-64.
101. Shih I-M, Kurman RJ: Expression of melanoma cell adhesion molecule in intermediate trophoblast. Lab Invest 1996; 75:377-388.
102. Hall S, Lorincz A, Shah F, Sherman ME, Abbas F, Paull G, Kurman RJ, Shah KV: Human papillomavirus DNA detection in cervical specimens by hybrid capture: Correlation with cytologic and histologic diagnoses of squamous intraepithelial lesions of the cervix. Gynecol Oncol 1996;62:353-359.
103. Burks RT, Sherman ME, Kurman RJ. Micropapillary serous carcinoma of the ovary. A distinctive low-grade carcinoma related to serous borderline tumors. Am J Surg Pathol 1996; 20:1319-1330.
104. Seidman JD, Kurman RJ. Subclassification of serous borderline tumors of the ovary into benign and malignant types. A clinicopathologic study of 65 advanced stage cases. Am J Surg Pathol 1996; 20:1331-1345.
105. Sun Y, Hildesheim A, Brinton LA, Nasca PC, Trimble CL, Kurman RJ, Viscidi RP, Shah KV. Human papillomavirus-specific serologic response in vulvar neoplasia. Gynecol Oncol 1996; 63:200-203.
106. Zaino RJ, Kurman RJ, Diana KL, Morrow CP. Pathologic models to predict outcome for women with endometrial adenocarcinoma. Cancer 1996; 77:1115-1121.
107. Ronnett BM, Shmookler BM, Diener-West M, Sugarbaker PH, Kurman RJ. Immunohistochemical evidence supporting the appendiceal origin of pseudomyxoma peritonei in women. Int J Gynecol Pathol 1997; 16:1-9.
108. Pizer ES, Kurman RJ, Pasternack GR, Kuhajda FP. Expression of fatty acid synthase is closely linked to proliferation and stromal decidualization in cycling endometrium. Int J Gynecol Pathol 1997; 16:45-51.
109. Tashiro H, Isacson C, Levine R, Kurman RJ, Cho KR, Hedrick L. p53 gene mutations are common in uterine serous carcinoma and occur early in their pathogenesis. Am J Pathol 1997;150:177-185.
110. Cina SF, Richardson MS, Austin RM, Kurman RJ. Immunohistochemical staining for Ki-67 antigen, carcinoembryonic antigen, and p53 in the differential diagnosis of glandular lesions of the cervix. Mod Pathol 1997;10(3):176-180
111. Wu TC, Fuentes-Bernardo DA, Chan Y-J, Au W-C, Choiu C-J, Fox WM III, Hruban RH, Hayward GS, Kurman RJ. Detection of the human cytomegalovirs 2.0-kb immediate early gene 1 transcrips in permissive and nonpermissive infections by RNA in situ hybridization. J Biomed Sci 1997;4:19-27.
112. Sherman ME, Schiffman MH, Mango LJ, Kelly D, Acosta D, Cason Z, Elgert P, Zaleski S. Scott DR, Kurman RJ, Stoler M, Lorincz AT. Evaluation of PAPNET testing as an ancillary tool to clarify the status of the “atypical” cervical smear. Mod Pathol 1997;10(6):564-571.
113. Randall TC, Kurman RJ. Progestin treatment of atypical hyperplasia and well-differentiated carcinoma of the endometrium in women under age 40. Obstet Gynecol 1997;90:434-440.
114. Cope JU, Hildesheim A, Schiffman MH, Manos MM, Lorincz AT, Burk RD, Glass AG, Greer C, Buckland J, Helgesen K, Scott DR, Sherman ME, Kurman RJ, Kiaw K-L. Comparison of the hybrid capture tube test and PCR for detection of human papillomavirus DNA in cervical speciments. J Clin Microbiol 1997; 35:2262-2265.
115. Hildesheim A, Han C-L, Brinton LA, Kurman RJ, Schiller JT. Human papillomavirus Type 16 and risk of preinvasive and invasive vulvar cancer: Results from a seroepidemiological case-control study. Obstet Gynecol 1997;90:748-54.
116. Sherman ME, Sturgeon, S, Brinton LA, Potischman N, Kurman RJ, Berman ML, Mortel R, Twiggs LB, Barrett RJ, Wilbanks GD. Risk factors and hormone levels in patients with serous and endometrioid uterine carcinomas. Mod Pathol 1997;10(10):963-968.
117. Shih I-M, Schnaar RL, Gearhart JD, Kurman RJ. Distribution of cells bearing the HNK-1 epitope in the human placenta. Placenta 1997; 18:667-674.
118. Ronnett BM, Kurman RJ, Shmookler BM, Sugarbaker PH, Young RH. The morphologic spectrum of ovarian metastases of appendiceal adenocarcinomas. A clinicopathologic and immunohistochemical analysis of tumors often misinterpreted as primary ovarian tumors or metastatic tumors from other gastrointestinal sites. Am J Surg Pathol 1997; 21:1144-1155.
119. Hildesheim A, Schiffman MK, Tsukui T, Swanson CA, Lucci J, Scott DR, Glass AG, Rush BB, Lorincz, AT, Corrigan A, Burk RD, Helgesen K, Houghten RA, Sherman ME, Kurman RJ, Berzofsky JA, Kramer TR. Immune activation in cervical neoplasia:cross-sectional association between plasma soluble interleukin 2 receptor levels and disease. Cancer Epidemiol Biomarkers Prev 1997; 10:807-13
120. Madeleine MM, Daling JR, Carter JJ, Wipf GC, Schwartz SM, McKnight B, Kurman RJ, Beckmann AM, Hagensee ME, Galloway DA. Cofactors with human papillomavirus in a population-based study of vulvar cancer. J Natl Cancer Inst 1997; 89:1516-23
121. Wu T-C, Hseih ST, Purow BW, Kurman RJ. Demonstration of human papillomavirus (HPV) genomic amplification and viral-like particles from CaSki cell line in SCID mice. J Virol Methods 1997; 65:287-98
122. Strickler HD, Schiffman MH, Eklund C, Glass AG, Scott DR, Sherman ME, Wacholder S, Kurman RJ, Manos MM, Schiller JT, Dillner J. Evidence for at least two distinct groups of humoral reactions to papillomavirus antigens in women with squamous intraepithelial lesions. Cancer Epidemiol Biomarkers Prev 1997; 6:183-8
123. Riopel MA, Perlman EJ, Seidman JD, Kurman RJ, Sherman ME. Inhibin and epithelial membrane antigen immunohistochemistry assist in the diagnosis of sex cord stromal tumors and provide clues to the histogenesis of hypercalcemis small cell carcinomas. Int J Gynecol Pathol 1998; 17:46-53.
124. Katabuchi H, Tashiro H, Cho KR, Kurman RJ, Ellenson LH. Micropapillary serous carcinoma of the ovary: an immunohistochemical and mutational analysis of p53. Int J Gynecol Pathol 1998; 17:54-60.
125. Shih I-M, Kurman RJ. Ki-67 labeling index in the differential diagnosis of exaggerated placental site trophoblastic tumor, and choriocarcinoma. Hum Pathol 1998; 28:27-33.
126. Vu K, Greenspan DL, Wu T-C, Zacur HA, Kurman RJ. Cellular proliferation, estrogen receptor, progesterone receptor, and bcl-2 expression in GnRH agonist-treated uterine leiomyomas. Hum Pathol 1998; 29:359-363.
127. Lax SF, Pizer ES, Ronnett BM, Kurman RJ. Clear cell carcinoma of the endometrium is characterized by a distinctive profile of p53, Ki-67, estrogen, and progesterone receptor expression. Hum Pathol 1998; 29:551-558.
128. Zelmanowicz A, Hildesheim A, Sherman ME, Sturgeon SR, Kurman RJ, Barrett RJ, Berman ML, Mortel R, Twiggs LB, Wilbanks GD, Brinton LA. Evidence for a common etiology for endometrial carcinomas and malignant mixed mullerian tumors. Gynecol Oncol 1998; 69:253-257.
129. Pizer ES, Lax SF, Kuhajda FP, Pasternack GR, Kurman RJ. Fatty acid synthase expression in endometrial carcinoma. Correlation with cell proliferation and hormone receptors. Cancer 1998; 83:528-537.
130. Kendall BS, Ronnett BM, Isacson C, Cho KR, Hedrick L, Diener-West M, Kurman RJ. Reproducibility of the diagnosis of endometrial hyperplasia, atypical hyperplasia, and well-differentiated carcinoma. Am J Surg Pathol 1998; 22:1012-1019.
131. Levine RL, Cargile CB, Blazes MS, van Rees B, Kurman RJ, Ellenson LH. PTEN mutations and microsatellite instability in complex atypical hyperplasia, a precursor lesion to uterine endometrioid carcinoma. Ca Res 1998; 58:3254- 3258.
132. Shih I-M, Wang T-L, Wu T-C, Kurman RJ, Gearhart JD. Expression of Mel-CAM in implantation site intermediate trophoblastic cell line, IST-1, limits its migration on uterine smooth muscle cells. J Cell Sci 1998; 111:2655-2664.
133. Ji H, Chang EY, Lin K-Y, Kurman RJ, Pardoll DM, Wu T-C. Antigen-specific immunotherapy for murine lung metastatic tumors expressing human papillomavirus type 16 E7 oncoprotein. Int J Cancer 1998; 78:41-45.
134. Lax SF, Pizer ES, Ronnett BM, Kurman RJ. Comparison of estrogen and progesterone receptor, Ki-67, and p53 immunoreactivity in uterine endometrioid carcinoma and endometrioid carcinoma with squamous, mucinous, secretory, and ciliated cell differentiation. Hum Pathol 1998; 29:924-931.
135. Zaino RJ, Kurman RJ, Brunetto VL, Morrow CP, Bentley RC, Cappellari JO, Bitterman P. Villoglandular adenocarcinoma of the endometrium: A clinicopathologic study of 61 cases. Am J Surg Pathol 1998; 22:1379-1385.
136. Shih I-M, Kurman RJ. Epithelioid trophoblastic tumor: A neoplasm distinct from choriocarcinoma and placental site trophoblastic tumor simulating carcinoma. Am J Surg Pathol 1998; 22(11):1393-1403.
137. Shih I-M, Nesbit M, Herlyn M, Kurman RJ. A new Mel-CAM (CD146)-specific monoclonal antibody, MN-4, on paraffin-embedded tissue. Mod Pathol 1998; 11(11):1098-1106.
138. Huang C-C, Qiu JT, Kashima ML, Kurman RJ, Wu T-C. Generation of type-specific probes for the detection of single-copy Human papillomavirus by a novel in situ hybridization method. Mod Pathol 1998; 11 (10):971-977.
139. Sherman ME, Tabbara SO, Scott DR, Kurman RJ, Glass AG, Manos MM, Burk RD, Rush BB, Schiffman M. “ASCUS, rule out HSIL”:Cytologic features, histologic correlates, and Human Papillomavirus detection. Mod Pathol 1999; 12 (4):335-342.
140. Sherman ME, Lee JS, Burks RT, Struewing JP, Kurman RJ, Hartge P. Histopathologic features of ovaries at increased risk for carcinoma:A case-control analysis. Int J Gynecol Pathol 1999; 18:151-157.
141. Manos MM, Kinney WK, Hurley LB, Sherman ME, Shieh-Ngai J, Kurman RJ, Ransley JE, Fetterman BJ, Hartinger JS, MacIntosh KM,Pawlick GF, Hiatt RA. Identifying women with cervical neoplasia. Using Human Papillomavirus DNA testing for equivocal Papanicolaou results. JAMA 1999; 281 (17):1605-1610.
142. Huang C-C, Kashima ML, Chen H, Shih I-M, Kurman RJ, Wu T-C. HPV in situ hybridization with catalyzed signal amplification and polymerase chain reaction in establishing cerebellar metastasis of a cervical carcinoma. Hum Pathol 1999; 30(5):587-591.
143. Shih I-M, Kurman RJ. Immunohistochemical Localization of inhibin-I in the placenta and gestational trophoblastic lesions. Int J Gynecol Pathol 1999; 18(2):144-150.
144. Trimble CL, Diener-West M, Wilkinson EJ, Zaino RJ, Kurman RJ, Shah KV. Reproducibility of the histopathologic classification of vulvar squamous carcinoma and intraepithelial neoplasia. Journal of Lower Genital Tract Disease 1999; 3 (2):98-103.
145. Riopel MA, Ronnett BM, Kurman RJ. Evaluation of diagnostic criteria and behavior of ovarian intestinal-type mucinous tumors: Atypical proliferative (borderline) tumors and intraepithelial, microinvasive, and metastatic carcinomas. Am J Surg Pathol 1999; 23:617-635.
146. Shih I-M, Seidman JD, Kurman RJ. Placental site nodule and characterization of distinctive types of intermediate trophoblast. Hum Pathol 1999; 30:687-694.
147. Liaw K-L, Glass AG, Manos MM, Greer CE, Scott DR, Sherman M, Burk RD, Kurman RJ, Wacholder S, Rush BB, Cadell DM, Lawler P, Tabor D, Schiffman M. Detection of Human Papillomavirus DNA in cytologically normal women and subsequent cervical squamous intraepithelial lesions. J Natl Cancer Inst 1999; 91:954-960.
148. Ronnett BM, Manos MM, Ransley JE, Fetterman BJ, Kinney WK, Hurley LB, Ngai JS, Kurman RJ, Sherman ME. Atypical glandular cells of undetermined significance (AGUS): Cytopathologic features, histopathologic results, and Human Papillomavirus DNA detection. Hum Pathol 1999; 30(7):816-825.
149. Ji H, Wang T-L, Chen C-H, Pai SI, Hung C-F, Lin K-Y, Kurman RJ, Pardoll DM, Wu T-C. Targeting human papillomavirus type 16 E7 to the endosomal/lysosomal vaccines against Murine human papillomavirus type 16 E7-expressing tumors. Human Gene Therapy 1999; 10:2727-2740.
150. Kurtz AB, Tsimikas JV, Tempany CMC, Hamper UM, Arger PH, Bree RL, Wechesler RJ, Francis IR, Kuhlman JE, Siegelman ES, Mitchell DG, Silverman SG, Brown DL, Sheth S, Coleman BG, Ellis JH, Kurman RJ, Caudry DJ, McNeil BJ. Diagnosis and staging of ovarian cancer: Comparative values of Doppler and conventional US, CT, and MR imaging correlated with surgery and histopathologic analysis—Report of the Radiology Diagnostic Oncology Group. Radiology 1999; 212:19-27.
151. Lacey JV Jr., Brinton LA, Barnes WA, Gravitt PE, Greenberg MD, Hadjimichael OC, McGowan L, Mortel R, Schwartz PE, Kurman RJ, Hildesheim A. Use of hormone replacement therapy and adenocarcinomas and squamous cell carcinomas of the uterine cervix. Gynecol Oncol 2000; 77:149-154.
152. Chang EY, Chen C-H, Ji H, Wang T-L, Hung K, Lee BP, Huang AYC, Kurman RJ, Pardoll DM, Wu TC. Antigen-specific cancer immunotherapy using a GM-CSF secreting allogeneic tumor cell-based vaccine. Int J Cancer 2000; 86:725-730.
153. Wheeler DT, Bell KA, Kurman RJ, Sherman ME. Minimal uterine serous carcinoma:Diagnosis and clinicopathologic correlation. Am J Surg Pathol 2000; 24 (6):797-806.
154. Wang TL, Ling M, Shih I-M, Pham T, Pai SI, Lu Z, Kurman RJ, Pardoll DM. Intramuscular administration of E7-transfected dendritic cells generates the most potent E7-specific anti-tumor immunity. Gene Therapy 2000; 7:726-733.
155. Hinton EL, Bobo LD, Wu T-C, Kurman RJ, Viscidi RP. Detection of chlamydia trachomatis deoxyribonucleic acid in archival paraffinized specimens from chronic salpingitis cases using the polymerase chain reaction. Fert Steril 2000; 74:1-6.
156. Kurman RJ, Felix JC, Archer DF, Nanavati N, Arce J-C, Moyer DL. Norethindrone acetate and estradiol-induced endometrial hyperplasia. Obstet Gynecol 2000; 96:373-79.
157. Chew SH, Perlman EJ, Williams R, Kurman RJ, Ronnett BM. Morphology and DNA content analysis in the evaluation of first trimester placentas for partial hydatidiform mole (PHM). Hum Pathol 2000; 31 (8):914-924.
158. Lax SF, Kurman RJ, Pizer ES, Wu L, Ronnett BM. A binary architectural grading system for uterine endometrial carcinoma has superior reproducibility compared with FIGO grading and identifies subsets of advance-stage tumors with favorable and unfavorable prognosis. Am J Surg Pathol 2000; 24 (9):1201-1208.
159. Bell KA, Kurman, RJ. A clinicopathologic analysis of atypical proliferative (Borderline) tumors and well-differentiated endometrioid adenocarcinoma of the ovary. Am J Surg Pathol 2000; 24 (11):1465-1479.
160. Raymond EG, Lovely LP, Chen-Mok M, Seppala M, Kurman RJ, Lessey BA. Effect of the Yuzpe regimen of emergency contraception on markers of endometrial receptivity. Hum Reprod 2000; 15:2351-5.
161. Bell KA, Smith Sehdev AE, Kurman RJ. Refined diagnostic criteria for implants associated with ovarian atypical proliferative serous tumors (borderline) with micropapillary serous carcinomas. Am J Surg Pathol 2001; 25 (4):419-432.
162. Moyer DL, Felix JC, Kurman RJ, Cuffie CA. Micronized progesterone reculation of endometrial glandular cycling pool. Int J Gynecol Pathol 2001; 20:374-379.
163. Ronnett BM, Yan H, Kurman RJ, Shmookler BM, Wu L, Sugarbaker PH. Patients with pseudomyxoma peritonei associated with disseminated peritoneal adenomucinosis have a significantly more favorable prognosis than patients with peritoneal mucinous carcinomatosis. Cancer 2001; 92:85-91.
164. Liaw K-L, Hildesheim A, Burk RD, Gravitt P, Wacholder S, Manos MM, Scott DR, Sherman ME, Kurman RJ, Glass AG, Anderson SM, Schiffman M. A perspective study of human papillomavirus (HPV) type 16 DNA detection by polymerase chain reaction and its association with acquisition and persistence of other HPV types. J Infect Dis 2001; 183:8-15.
165. Staebler A, Hesel-Meyer K, Bell K, Riopel M, Perlman E, Ried T, Kurman RJ. Micropapillary serous carcinoma of the ovary has distinct patterns of chromosomal imbalances by comparative genomic hybridization compared with atypical proliferative serous tumors and serous carcinomas. Hum Pathol 2002; 33:47-59.
166. Singer G, Kurman RJ, Chang H-W, Cho SKR, Shih IM. Diverse tumorigenic pathways in ovarian serous carcinoma. Am J Pathol 2002; 160:1223-1228.
167. Solomon D, Davey D, Kurman R, Moriarity A, O’Connor D, Prey M, Raab S, Sherman M, Wilbur D, Wright T, Young N. The 2001 Bethesda System. Terminology for reporting results of cervical cytology. JAMA 2002; 287:2114-2119.
168. Seidman JD, Sherman ME, Bell KA, Katabuchi H, Kurman RJ. Salpingitis, salpingoliths, and serous tumors of the ovary:Is there a connection? Int J Gynecol Pathol 2002; 21:101-107.
169. Singer G, Kurman RJ, McMaster MT, Shih I-M. HLA-G immunoreactivity is specific for intermediate trophoblast in gestational trophoblastic disease and can serve as a useful marker in differential diagnosis. Am J Surg Pathol 2002; 26:914-920.
170. Scott DR, Hagmar B, Maddox P, Hjerpe A, Dillner J, Cuzick J, Sherman ME, Stoler MH, Kurman RJ, Kiviat NB, Manos MM, Schiffman M. Use of human papillomavirus DNA testing to compare equivocal cervical cytologic interpretations in the United States, Scandinavia, and the United Kingdom. Cancer Cytopathology 2002; 96:14-20.
171. Montz FJ, Bristow RE, Bovicelli A, Tomacruz R, Kurman RJ. Intrauterine progesterone treatment of early endometrial cancer. Am J Obstet Gynecol 2002; 186:651-7.
172. Chang H-W, Ali SZ, Cho SKR, Kurman RJ, Shih I-M. Detection of allelic imbalance in asctic supernatant by digital single nucleotide polymorphism analysis. Clin Cancer Res 2002; 8:2580-2585.
173. Old RJ, Kurman RJ, Shih I-M. Molecular genetic analysis of placental site trophoblastic tumors and epithelioid trophoblastic tumors confirms their trophoblastic origin. Amer J Pathol 2002; 161:1033-1037.
174. Ji H, Isacson C, Seidman JD, Kurman RJ, Ronnett BM. Cytokeratins 7 and 20, Dpc4 and MUC5AC in the distinction of metastatic mucinous carcinomas in the ovary from primary ovarian mucinous tumors: Dpc4 assists in identifying metastatic pancreatic carcinomas. Int J Gynecol Pathol 2002; 21:391-400.
175. Shih I-M, Hsu M-Y, Oldt III RJ, Herlyn M, Gearhart JD, Kurman RJ. The role of E-cadherin in the motility and invasion of implantation site intermediate trophoblast. Placenta 2002; 23:706-715.
176. Chang H-W, Lee SM, Goodman SN, Singer G, Cho SKR, Sokoll LJ, Montz FJ, Roden R, Zhang Z, Chan DW, Kurman RJ, Shih I-M. Assessment of plasma DNA levels, allelic imbalance, and CA 125 as diagnostic tests for cancer. J Natl Cancer Inst 2002 ; 94:1697-1703.
177. Klaes R, Benner A, Friedrich T, Ridder R, Herrington S, Jenkins D, Kurman RJ, Schmidt D, Stoler M, von Knebel M. p16INK4A immunohistochemistry improves interobserver agreement in the diagnosis of cervical intraepithelial neoplasia. Am J Surg Pathol 2002; 26(11):1389-1399.
178. Movahedi-Lankarani S, Kurman RJ. Calretinin, a more sensitive but less specific marker than alpha-inhibin for ovarian sex cord-stromal neoplasms:An immunohistochemical study of 215 cases. Am J Surg Pathol 2002; 26:1477-1483.
179. Shappell H, Riopel MA, Smith Sedhev AE, Ronnett BM, Kurman RJ. Diagnostic criteria and behavior of seromucinous (endocervical-type mucinous and mixed cell-type) tumors. Atypical proliferative (borderline) tumors, intraepithelial, microinvasive, and invasive carcinomas. Am J Surg Pathol 2002; 26:1529-41.
180. Singer G, Shih I-M, Truskinovsky A, Umudum H, Kurman RJ. Mutational analysis of K-ras segregates ovarian serous carcinoma into two types:Invasive MPSC (low-grade serous tumor) and conventional serous carcoma (high-grade tumor). Int J Gynecol Pathol 2003; 22:37-41.
181. Smith Sehdev AE, Sehdev PS, Kurman RJ. Noninvasive and invasive micropapillary (low grade) serous carcinoma of the ovary:A clinicopathologic analysis of 135 cases. Am J Surg Pathol 2003; 27(6):725-36.
182. Srodon M, Klein WM, Kurman RJ. CD10 immunostaining does not distinguish endometrial carcinoma invading myometrium from carcinoma involving adenomyosis. Am J Surg Pathol 2003; 27(6):786-89.
183. Singer G, Oldt R III, Cohen Y, Wang B, Sidransky D, Kurman RJ, Shih I-M. Mutations in BRAF and KRAS charaterize the development of low-grade ovarian serous carcinoma. J Natl Cancer Inst 2003; 95:484-486.
184. Seidman JD, Kurman RJ, Ronnett BM. Primary and metastatic mucinous adenocarcinomas in the ovaries:incidence in routine practice with a new approach to improve intraoperative diagnosis. Am J Surg Pathol 2003; 27:985-993.
185. Klein WM, Kurman RJ. Lack of expression of c-kit protein (CD117) in mesenchymal tumors of the uterus and ovary. Int J Gynecol Pathol 2003; 22:181-184.
186. Singer G, Rebmann V, Chen Y-C, Liu H-T, Ali SZ, Reinsberg J, McMaster MT, Pfeiffer K, Chan DW, Wardelmann, Grosse-Wilde H, Cheng C-C, Kurman RJ, Shih I-M. HLA-G is a potential marker in malignant ascites. Clinical Cancer Research 2003; 9:4460-4464.
187. Burk RD, Terai M, Gravitt PE, Brinton LA, Kurman RJ, Barnes WA, Greenberg MD, Hadjimichael OC, Fu L, McGowan L, Mortel R, Schwartz PE, Hildesheim A. Distribution of human papillomavirus types 16 and 18 variants in squamous cell carcinomas and adenocarcinomas of the cervix. Cancer Research 2003; 63(21):7215-7220.
188. Seidman JD, Horkayne-Szakaly I, Haiba M, Boice CR, Kurman RJ, Ronnett BM. The histologic type and stage distribution of ovarian carcinomas of surface epithelial origin. Int J Gynecol Pathol 2004; 23(1):41-44.
189. Cheng EJ, Kurman RJ, Wang M, Oldt III R, Wang BG, Berman DM, Shih Ie-M. Molecular genetic analysis of ovarian serous cystadenomas. Laboratory Investigation 2004; 84:778-784.
190. Shih I-M, Kurman RJ. P63 expression is useful in the distinction of epithelioid trophoblastic and placental site trophoblastic tumors by profiling trophoblastic subpopulations. Am J Surg Pathol 2004; September 28(9):1177-1183.
191. Hsu C-Y, Bristow R, Cha MS, Wang BG, Ho C-L, Kurman RJ, Wang T-L, Shih I-M. Characterization of active mitogen-activated protein kinase in ovarian serous carcinomas. Clin Cancer Res 10:6432-6436, 2004.
192. Singer G, Stohr R, Cope L, Dehari R, Hartmann A, Cao D-F, Wang TL, Kurman RJ, Shih IM. Patterns of p53 mutations separate ovarian serous borderline tumors, low and high-grade carcinomas and provide support for a new model of ovarian carcinogenesis. Am J Surg Pathol, 29(2):218-224, 2005.
193. Davidson B, Elstrand MB, McMaster MT, Berner A, Kurman RJ, Riseberg B, Trope CG, Shih I-M. HLA-G expression in effusions is a possible marker of tumor susceptibility to chemotherapy in ovarian carcinoma. Gynecol Oncol 96:42-47, 2005.
194. Pohl G, Ho C-L, Kurman RJ, Bristow R, Wang T-L, Shih I-M. Inactivation of the mitogen-activated protein kinase pathway as a potential target-based therapy in ovarian serous tumors with KRAS or BRAF mutations. Cancer Res 65(5):1-7, 2005.
195. Singer G, Stohr R, Cope L, Dehari R, Hartmann A, Cao D-F, Wang T-L, Kurman RJ, Shih I-M. Patterns of p53 mutations separate ovarian serous borderline tumors and low- and high-grade serous carcinomas and provide support for a new model of ovarian carcinogenesis. A mutational analysis with immunohistochemical correlation. Am J Surg Pathol 29:218-224, 2005.
196. Elishaev E, Gilks B, Miller D, Srodon M, Kurman RJ, Ronnett BM. Synchronous and metachronous endocervical and ovarian neoplasms. Evidence supporting interpretation of the ovarian neoplasms as metastatic endocervical adenocarcinoma simulating primary ovarian surface epithelial epithelial neoplasms. Am J Surg Pathol 29:281-294,2005.
197. Pohl G, Ho C-L, Kurman RJ, Bristow R, Wang, T-L, Shih I-M. Inactivation of the mitogen-activated protein kinase pathway as a potential target-based therapy in ovarian serous tumors with KRAS or BRAF mutations. Cancer Res 65(5):1994-2000, 2005.
198. Parwani AV, Smith Sehdev AE, Kurman RJ, Ronnett BM. Cervical adenoid basal tumors comprised of adenoid basal epithelioma associated with various types of invasive carcinoma: Clinicopathologic features, human papillomavirus DNA detection, and P16 expression. Human Pathol 36:82-90, 2005.
199. Wheeler DT, Kurman RJ. The relationship of glands to thick-wall blood vessels as a marker of invasion in endocervical adenocarcinomas. Int J Gynecol Pathol 24(2):125-130, 2005.
200. Cao D, Srodon M, Montgomery EA, Kurman RJ. Lipomatous variant of angiomyofibroblastoma: Report of two cases and review of the literature. Int J Gynecol Pathol 24(2):196-200, 2005.
201. Villa LL, et al. (Kurman RJ among 28 co-authors) Prophylactic quadrivalent human papillomavirus (types 6, 11, 16, and 18) L1 virus-like particle vaccine in young women: a randomized double-blind placebo-controlled multicentre phase II efficacy trial. Lancet Oncol 6(5):271-278, 2005.
202. Shih I-M, Sheu JJ-C, Santillan A, Nakayama K, Yen MJ, Bristow RE, Vang R, Pamigiani G, Kurman RJ, Trope CG, Davidson B, and Wang T-L. Amplification of a chromatin remodeling gene, Rsf-1 HBXAP, in ovarian carcinoma. PNAS 102(39):14004-14009, 2005.
203. Hsu C-Y, Kurman RJ, Vang R, Wang T-L, Baak J, Shih I-M. Nuclear size distinguishes low- from high-grade ovarian serous carcinoma and predicts outcome. Hum Pathol 36:1049-54, 2005.
204. Diaz-Montes TP, Hongziu J, Sehdev AES, Zahurak ML, Kurman RJ, Armstrong DK, Bristow RE. Clinical significance of Her-2/neu overexpression in uterine serous carcinoma. Gynecologic Oncology 100:139-144, 2006.
205. Begum M, Tashiro H, Katabuchi H, Suzuki A, Kurman RJ, Okamura H. Neonatal estrogenic exposure suppresses PTEN-related endometrial carcinogenesis in recombinant mice. Laboratory Investigation 86:286-296, 2006.
206. Park JT, Li M, Nakayama K, Mao TL, Davidson B, Zhang Z, Kurman RJ, Eberhart CG, Shih IM, Wang TL. Notch-3 gene amplification in ovarian cancer. Cancer Res, 66:6312-6318, 2006.
207. Mao TL, Hsu CY, Yen MJ, Gilks B, Sheu JJC, Gabrielson E, Vang R, Cope L, Kurman RJ, Wang TL, Shih, IM. Expression of Rsf-1, a chromatin-remodeling gene, in ovarian and breast carcinoma. Hum Pathol 37:1169-1175, 2006.
208. Nakayama K, Nakayama N, Davidson B, Katabuchi H, Kurman RJ, Velculescu VE, Shih IM, Want TL. Homozygous deletion of MKK4 in ovarian serous carcinoma. Cancer Biology & Therapy 5(6):630-634, 2006.
209. Nakayama K, Nakayama N, Kurman RJ, Cope L, Pohl G, Samhuels Y, Velculescu VE, Wang TL, Shih IM. Sequence mutations and amplification of PIK3CA and AKT2 genes in purified ovarian serous neoplasms. Cancer Biology & Therapy 5(7):780-785, 2006.
210. Mao TL, Seidman JD, Kurman RJ, Shih IM. Cyclin E and p16 immunoreactivity in epithelioid trophoblastic tumor—An aid in differential diagnosis. Am J Surg Pathol 30(9):1105-1110, 2006.
211. Srodon M, Stoler MH, Baber GB, Kurman RJ. The distribution of low and high-risk HPV types in vulvar and vaginal intraepithelial neoplasia (VIN and VaIN). Am J Surg Pathol 30(12):1513-1518, 2006.
212. Wang SS, Sherman ME, Silverberg SG, Carreon JD, Lacey JV, Jr., Zaino R, Kurman RJ, Hildesheim A. Pathological characteristics of cervical adenocarcinoma in a multi-center U.S.-based study. Gynecologic Oncology 103:541-546, 2006.
213. Nakayama K, Nakayama N, Davidson B, Sheu J J-C, Jnawath N, Santillan A, Salani R, Bristow RE, Morin PJ, Kurman RJ, Wang T-L, Shih Ie-M. A BPB/POZ protein, NAC-1, is related to tumor recurrence and is essential for tumor growth and survival. PNAS 103(49):18739-18744, 2006.
214. Salani R, Neuberger I, Kurman RJ, Bristow RE, Change HW, Wang, TL, Shih, IM. Expression of extracellular matrix proteins in ovarian serous tumors. Int J Gynecol Pathol 26(2):141-146, 2007.
215. Wheeler DT, Bristow RE, Kurman RJ. Histologic alterations in endometrial hyperplasia and well-differentiated carcinoma treated with progestins. Am J Surg Pathol 31:988-998, 2007
216. Dehari R, Kurman RJ, Logani S, Shih I-M. The development of high-grade serous carcinoma from atypical proliferative (borderline) serous tumors and low-grade micropapillary serous carcinoma. A morphologic and molecular genetic analysis. Am J Surg Pathol 31:1007-1012, 2007
217. Malpica A, Deavers MT, Tornos C, Kurman RJ, Soslow R, Seidman JD, Munsell MF, Gaertner E, Frishberg D, Silva EG. Interobserver and intraobserver variability of a two-tier system for gradinig ovarian serous carcinoma. Am J Surg Pathol 31(8):1168-1174, 2007
218. Salani R, Kurman RJ, Giuntoli R, Gardner G, Bristow R, Want T-L, Shih I-M. Assessment of TP53 mutation using purified tissue samples of ovarian serous carcinomas reveals a higher mutation rate than previously reported and does not correlate with drug resistance. Int J Gynecol Cancer 18:487-491, 2008
219. Mao TL, Kurman RJ, Jeng YM, Huang W, Shih IM. HSD3B1 as a novel trophoblast-associated marker that assists in the differential diagnosis of trophoblastic tumors and tumorlike lesions. Am J Surg Pathol 32(2):236-242, 2008
220. Vang V, Shih IM, Salani R, Sugar E, Ayhan A, Kurman RJ. Subdividing ovarian and peritoneal serous carcinoma into moderately differentiated and poorly differentiated does not have biologic validity based on molecular genetic and in vitro drug resistance data. Am J Surg Pathol 32(11):1667-1674, 2008
221. Yemelyanova A, Mao, T-L, Nakayama N, Shih, I-M, Kurman RJ. Low-grade serous carcinoma of the ovary displaying a macropapillary pattern of invasion. Am J Surg Pathol 32(12):1800-1806, 2008
222. Ronnett BM, Yemelyanova AV, Vang R, Gilks CB, Miller D, Gravitt PE, Kurman RJ. Endocervical adenocarcinomas with ovarian metastases: Analysis of 29 cases with emphasis on minimally invasive cervical tumors and the ability of the metastases to simulate priary ovarian neoplasms. Am J Surg Pathol 32(12):1835-1853, 2008
223. Moore RG, McMeekin DS, Brown AK, DiSilvestro P, Miller MC, Allard WJ, Gajewski W, Kurman R, Bast Jr. RC, Skates SJ. “A novel multiple marker bioassay utilizing HE4 and CA125 for the prediction of ovarian cancer in patients with a pelvic mass. Gynecologic Oncology 112:40-46, 2009.
224. Smith JS, BackesDM, Hoots BE, Kurman RJ, Pimenta JM. Human papillomavirus type-distribution in vulvar and vaginal cancers and their associated precursors. Obstet Gynecol 113:917-924, 2009.
225. Kuo K-T, Mao T-L, Jones S, Veras E, Ayhan A, Wang T-L, Glas R, Slamon D, Velculescu V, Kurman RJ, Shih I-M. Frequent activating mutations of PIK3CA in ovarian clear cell carcinoma. AJP 174(5):1597-1601, 2009.
226. Veras E, Mao TL, Ayhan A, Ueda S, Lai H, Hayran M, Shih IeM, Kurman RJ. Cystic and adenofibromatous clear cell carcinomas of the ovary: Distinctive tumors that differ in their pathogenesis and behavior: A clinicopathologic analysis of 122 cases. Am J Surg Pathol 33(6):844-853, 2009.
227. Ayhan A, Kurman RJ, Yemelyanova A, Vang R, Logani S, Seidman JD, Shih IeM. Defining the cut point between low-grade and high-grade ovarian serous carcinoma: A clinicopathoogic and molecular genetic analysis. Am J Surg Pathol 33(8):1220-1224. 2009.
228. Kuo K-T, Guan B, Mao T-L, Chen X, Jinawath N, Wang Y, Kurman RJ, Shih I-M, Wang T-L. Analysis of DNA copy number alterations in ovarian serous tumors identifies new molecular genetic changes in low-grade and high-grade carcinomas. Cancer Res 69:4036-42, 2009.
229. Backes DM, Kurman RJ, Pimenta JM, Smith JS. Systematic review of human papillomavirus prevalence in invasive penile cancer. Cancer Causes Control 20:449-57, 2009.
230. Ueda SM, Mao T-L, Kuhajda FP, V C, Giuntoli RL, Bristow RE, Kurman RJ, Shih Ie-M. Trophoblastic neoplasms express fatty acid synthase, which may be a therapeutic target via its inhibitor C93. AJP 175(6):2619-2624, 2009.
231. Brown DR, Kjaer SK, Sgurdsson K, Iversen O-E, Hernandez-Avila M, Wheeler CM, Perez G, Koutsky LA, Tay EH, Garcia P, Ault KA, Garland SM, Leodolter S, Olsen S-E, Tang GWK, Ferris DG, Paavonen J, Steben M, Bosch FX, Dillner J, Joura EA, Kurman RJ, Majewski S, Munoz N, Myers ER, Villa LL, Taddeo RJ, Roberts C, Tadesse A, Bryan J, Lupinacci LC, Giacoletti KED, Sings HL, James M, Hesley TM, Barr E. The impact of quadrivalent human papillomavirus (HPV; types 6, 11, 16, and 18) L1 virus-like particle vaccine on infection and disease due to oncogenic nonvaccine HPV types in generally HPV-naïve women aged 16026 years. J Infect Dis 2009; 199:926-935.
232. Witkiewicz AK, McConnell T, Potoczek M, Emmons RVB, Kurman RJ. Increased natural killer cells and decreased regulatory T cells are seen in complex atypical endometrial hyperplasia and well-differentiated carcinoma treated with progestins. Human Pathology 41:26-32, 2010.
233. Kuhn E, Meeker A, Wang TL, Sehdev AS, Kurman RJ, Shih Ie-M. Shortened telomeres in serous tubal intraepithelial carcinoma: An early event in ovarian high-grade serous carcinogenesis. Am J Surg Pathol 34:829-836, 2010.
234. Sehdev AS, Kurman RJ, Kuhn E, Shih Ie-M. Serous tubal intraepithelial carcinoma upregulates markers associated with high-grade serous carcinomas including Rsf-1 (HBXAP), cyclin E and fatty acid synthase. Modern Pathology 23:844-855, 2010.
235. Seidman JD, Yemyelyanova A, Zaino RJ, Kurman RJ. The fallopian tube-peritoneal junction: A potential site of carcinogenesis. Int J Gynecol Pathol 30:4-11, 2010
236. Shih I-M, Chen L, Wang CC, Gu J, Davidson B, Cope L, Wang T-L. Distinct DNA methylation profiles in ovarian serous neoplasms and their implications in ovarian carcinogenesis. Am J Obstet Gynecol 2010;203:584.e1-22
237. Shih I-M, Panuganti PK, Kuo K-T, Mao T-L, Kuhn E, Jones S, Velculescu V, Kurman RJ, Wang T-L. Somatic mutations of PPP2Ria in ovarian and uterine carcinomas. Amer J Pathol 2011;178:1442-47
238. Guan B, Mao TL, Panuganti PK, Kuhn E, Kurman RJ, Maeda D, Chen E, Jeng YM, Wang TL, Shih IM. Mutation and loss of expression of ARID1A in uterine low-grade endometrioid carcinoma. Am J Surg Pathol. 2011 Mar 15. [Epub ahead of print] PMID:21412130
239. Yemelyanova A, Vang R, Kshirsagar M, Lu D, Marks MA, Shih IM, Kurman RJ. Immunohistochemical staining patterns of p53 can serve as a surrogate marker for TP53 mutations in ovarian carcinoma: an immunohistochemical and nucleotide sequencing analysis. Mod Pathol. 2011 May 6. [Epub ahead of print]
240. Kurman RJ, Vang R, Junge J, Gerd Hanibal C, Kjaer SK, Shih I-E. Papillary tubal hyperplasia: The putative precursor of ovarian atypical proliferative (borderline) serous tumors, noninvasive implants, and endosalpingiosis. Am J Surg Pathol 2011;35:1605–1614
241. Visvanathan K, Vang R, Shaw P, Gross A, Soslow, MD, Parkash V, Shih I-E, Kurman RJ. Diagnosis of serous tubal intraepithelial carcinoma based on morphologic and immunohistochemical features: A reproducibility study. Am J Surg Pathol 2011;00:000–000
242. Jones S, Wang T-L, Kurman RJ, Nakayama K, Velculesc VE, Vogelstein B, Kinzler KW, Papdopoulos N and Shih, IM. Low-grade serous carcinomas of the ovary contain very few point mutations. J Pathol 2012: 226-413-420.
243. Kuhn E, Kurman RJ, Vang R, Sehdev AS, Han G, Soslow R., Wang T-L, Shih IM. TP53 mutations in serous tubal intraepithelial carcinoma and concurrent pelvic high-grade serous carcinoma—evidence supporting the clonal relationship of the two lesions. J Pathol 2012; 226:421-426.
244. Vang R, Gupta M, Wu LSF, Yemelyanova AV, Kurman RJ, Murphy KM, DeScipio C and Ronnett BM. Diagnostic reproducibility of hydatidiform moles: Ancillary techniques (p57 immunohistochemistry and molecular genotyping) improve morphologic diagnosis. Am J Surg Pathol 2012; 36(3):443-453
245. Seidman JD, Yemelyanova A, Cosin JA, Smith A, Kurman RJ. Survival rates for international federation of gynecology and obstetrics stage III ovarian carcinoma by cell type: A study of 262 unselected patients with uniform pathologic review. Int J Gynecol Cancer 2012; 22:367-371.
Review Articles and Book Chapters:
1.Kurman RJ, and Norris HJ: Malignant germ cell tumors of the ovary. Human Pathol 1977; 8:551-564.
2. Kurman RJ, and Norris HJ: Germ cell tumors of the ovary. Path Annual 1978; 13:291-325.
3. Kurman RJ, Scardino PT, McIntire KR, Waldmann TA, Javadpour N, and Norris HJ: Cellular localization of alpha-fetoprotein and human chorionic gonadotropin in germ cell tumors of the testis and ovary. Scand J Immunol 1978; Supp 8, Vol 8, 127-130.
4. Kurman RJ: Abnormalities of the genital tract following stilbestrol exposure in utero. In Recent Results in Cancer Research. C.H. Lingeman (ed), Springer-Verlag, Berlin, Heidelberg, New York, 1979; Vol 66, pp. 161-174.
5. Kurman RJ: The clinical consequences of stilbestrol exposure in utero. West J Med 1979;
131:526-532.
6. Kurman RJ, Scardino PT, McIntire KR, Waldmann TA, Javadpour N, and Norris HJ: Malignant germ cell tumors of the ovary and testis. An immunohistologic study of 69 cases. Ann Clin Lab Sci 1979; 9:462-466.
7. Kurman RJ, and Norris HJ: The effect of in utero exposure to diethystilbestrol. In Functional Morphologic Changes in Female Sex Organs Induced by Exogenous Hormones. Dallenbach-Helwig (ed) Springer-Verlag, Berlin, Heidelberg, New York, 1980; pp. 7-16.
8. Kurman RJ and Casey C: Immunoperoxidase techniques in surgical pathology. Principles and practice. In Manual of Clinical Immunology, 2nd ed., Noel Rose and Herman Friedman (eds). American Society of Microbiology, Wash., D.C., 1980; pp. 60-69.
9. Kurman RJ, Goebelsmann U, and Taylor CR: Localization of steroid hormones in functional ovarian tumors. In Masson Monographs in Diagnostic Pathology. Diagnostic Immunocytochemistry A. DeLellis (ed) Masson, Inc., New York, 1981; pp. 137-148.
10. Kurman RJ, and Scardino PT: Alpha-fetoprotein and human chorionic gonadotropin in ovarian and testicular germ cell tumors. In Masson Monograph in Diagnostic Pathology. Diagnostic Immunocytochemistry A. DeLellis (ed) Masson, Inc., New York, 1981; pp. 277-298.
11. Robboy SJ, Miller AW III Jr., Kurman RJ: The pathologic features and behavior of endometrial carcinoma associated with exogenous estrogen administration. Path Res Pract 1982; 174:237-256.
12. Kurman RJ: Benign diseases of the endometrium. In Pathology of the Female Genital Tract. 2nd ed. Ancel Blaustein (ed). Springer-Verlag, Berlin, Heidelberg, New York, 1982; pp. 279-310.
13. Kurman RJ and Norris HJ: Endometrial neoplasia: Hyperplasia and carcinoma. In Pathology of the Female Genital Tract. 2nd ed. Blaustein (ed). Springer-Verlag, Berlin, Heidelberg, New York, 1982; pp. 311-351.
14. Kurman RJ, Petrilli ES: Germ cell tumors of the ovary. Pathology, behavior and treatment. In Cancer Research and Treatment. Gynecologic Cancer. C.T. Griffiths and A. Fuller (eds). Martinus Nijhoff, Boston, 1983; pp. 103-153.
15. Kurman RJ: Immunocytochemistry of testicular cancer. In Testis Tumors. J. Donohue (ed). Williams and Wilkins. Baltimore, 1983; pp. 92-110.
16. Zaloudek CJ, Kurman RJ: Recent advances in the pathology of ovarian cancer. In Clinics in Obstetrics and Gynecology. Ovarian Cancer. Vol. 10, No. 2, P.J. DiSaia (ed)., W.B. Saunders, London 1983; pp. 155-185.
17. Norris HJ, Tavassoli FA, Kurman RJ: Endometrial hyperplasia and carcinoma; Diagnostic considerations. Am J Surg Pathol 1983; 7:839-847.
18. Kaufman R, Koss LG, Kurman RJ, Meisels A, Okagaki T, Patten SF, Reid R, Richart RM, Weid GL. Statementof caution in the interpretation of papillomavirus-associated lesions of the epithelium of uterine cervix. Int J Gynecol Pathol 2(1):100,1983.
19. Kurman RJ: Contributions of immunocytochemistry to gynecologic pathology. In Clinics in Obstetrics and Gynecology, Vol. 11, No. 1, H. Fox (ed). W.B. Saunders, London, 1984; pp. 5-23.
20. Kurman RJ, Ganjei P, Nadji M: Contributions of immunocytochemistry to the diagnosis and study of ovarian neoplasms. Int J Gynecol Pathol 1984; 3:3-26.
21. Kurman RJ, Jenson AB, Sinclair CF, Lancaster WD: Detection of human papillomavirus by immunocytochemistry. In Advances in Immunocytochemistry, 2nd edition, R.A. DeLellis (ed). Masson, Inc., New York, 1984; pp. 201-221.
22. Jenson AB, Kurman RJ, Lancaster WD: The human papillomaviruses. In International Textbook of Human Virology, R. Belshe (ed), John Wright, PSG, Inc, 1984; pp. 951-968.
23. Kurman RJ, Jenson AB, Lancaster WD: The role of papillomavirus infection in squamous neoplasia of the cervix. Path Res Practice 1984; 179:24-30.
24. Kurman RJ: Pathology considerations in clinical chemoprevention trials. In Chemoprevention Clinical Trials, Problems and Solutions. Proceedings of a Workshop. M.A. Sestili and J. G. Dell (eds), 1984, pp. 139-142.
25. Kurman RJ: Cervical dysplasia. Classification and natural history. In Interferon in the Prevention of Cervical Carcinoma. National Cancer Institute Workshop, 1984, pp. 4-24.
26. Kurman RJ, and Nadji M: Immunocytochemistry of ovarian neoplasms, In Tumors and Tumor Like Conditions of the Ovary. L.M. Roth and B. Czernobilsky (eds); Contemporary Issues in Surgical Pathology. Churchill Livingston Inc. New York, Edinburgh, London and Melbourne 1985, pp. 207-231.
27. Kurman RJ, Lancaster WD, Jenson AB: Papillomaviruses and cervical neoplasia. Reflections on the past, perceptions of the present, and speculations on the future. In UCLA Symposium on Molecular and Cellular Biology. New Series. P. Howley and T. Broker (eds), Alan R. Liss, Inc. 1985, pp. 3-18.
28. Jenson AB, Kurman RJ, Lancaster WD: Detection of papillomavirus common antigens in lesions of the skin and mucosa. Clinics in Dermatology 1985; 3:56-63.
29. Klappenbach RS, Kurman RJ: Immunohistochemistry of Testicular Tumors in Pathology of the Testis, A. Talerman and L.M. Roth (eds), Churchill Livingston Inc., New York, Edinburgh, London and Melbourne 1986, pp. 169-179.
30. Zaloudek C, Tavassoli F, Kurman RJ: Malignant Lesions of the Ovary. In Obstetrics and Gynecology. 5th ed., D.N. Danforth and J.R. Scott (eds), J.B. Lippincott Co., Philadelphia, 1986, pp. 1133-1155.
31. Kurman RJ, Norris HJ: Endometrium. In The Pathology of Incipient Neoplasia, D.E. Henson and J. Albores-Saavedra, (eds), W.B. Saunders Co., Philadelphia, 1986, pp. 265-277.
32. Jenson AB, Lancaster WD, Kurman RJ: Uterine Cervix. In The Pathology of Incipient Neoplasia, D.E. Henson and J. Albores-Saavedra, (eds), W.B. Saunders Co., Philadelphia, 1986, pp. 249-263.
33. Brescia RJ, Jenson AB, Lancaster WD, Kurman RJ: The role of human papillomavirus in the pathogenesis and histologic classification of precancerous lesions of the cervix. Humn Pathol 1986; 6:552-559.
34. Lancaster WD, Kurman RJ, Jenson AB: Papillomaviruses in anogenital neoplasms. In The Human Oncogenic Viruses, A. Luderer and H. Weetall (eds), Humana Press; Clifton, N.J. 1986, pp. 153-183.
35. Lorincz AT, Lancaster WD, Kurman RJ, Jenson AB, and Temple GF: Characterization of human papillomaviruses in cervical neoplasia and their detection in routine clinical screening. In Petro R., and zur Hausen H (eds.), Viral Origins of Cervical Cancer. Banbury Report 21. Cold Spring Harbor Laboratory, Cold Spring Harbor, New York, 1986, pp. 225-237.
36. Norris HJ, Connor MP, Kurman RJ: Preinvasive lesions of the endometrium. In Clinical Obstetrics and Gynecology, Vol. 13, No. 3, W.Creasman (ed), W.B. Saunders, London, Philadelphia, Toronto, 1986; pp. 725-738.
37. Yeh I-T, Kurman RJ: Immunocytochemistry in obstetrics and gynecologic pathology. In Pathology Update Series, Vol. 2, Continuing Professional Educational Center, Inc., Princeton, New Jersey 1987, pp. 2-8.
38. Mazur MT, Kurman RJ: The pathology of gestational choriocarcinoma and placental site trophoblastic tumor In Gestational Trophoblastic Disease, A.E. Szulman and H. Buchsbaum (eds) Springer-Verlag, Berlin, Heidelberg, New York, 1987, pp. 45-68.
39. Jenson AB, Kurman RJ, Lancaster WD: Tissue effects of and host responses to human papillomavirus infection. In Clinical Obstetrics and Gynecology, Vol. 14, No 2, R. Reid (ed), W.B. Saunders, London, Philadelphia, Toronto, 1987; pp. 397-406.
40. Kurman RJ, Mazur MT: Benign disease of the endometrium. In Blaustein’s Pathology of the Female Genital Tract. 3rd ed. R.J. Kurman (ed). Springer-Verlag, Berlin, Heidelberg, New York, 1987, pp. 292-321.
41. Kurman RJ, Norris HJ: Endometrial hyperplasia and metaplasia. In Blaustein’s Pathology of the Female Genital Tract. 3rd ed. R.J. Kurman (ed). Springer-Verlag, Berlin, Heidelberg, New York, 1987, pp. 322-337.
42. Kurman RJ, Norris HJ: Endometrial carcinoma. In Blaustein’s Pathology of the Female Genital Tract. 3rd ed., R.J. Kurman (ed). Springer-Verlag, Berlin, Heidelberg, New York, 1987, pp. 338-372.
43. Mazur MT, Kurman RJ: Gestational trophoblastic disease. In Blaustein’s Pathology of the Female Genital Tract 3rd ed., R.J. Kurman (ed). Springer-Verlag, Berlin, Heidelberg, New York, 1987, pp. 835-875.
44. Robboy SJ, Kraus FT, Kurman RJ: Gross description and processing of gynecologic and obstetric tissue. In Blaustein’s Pathology of the Female Genital Tract. 3rd ed. R.J. Kurman (ed), Springer-Verlag, Berlin, Heidelberg, New York, 1987, pp. 925-940.
45. Robboy SJ, Duggan MA, Kurman RJ: The female reproductive system. In Pathology, E. Rubin and J. Farber (eds), J.B. Lippincott Co., Philadelphia, 1988, pp. 942-989.
46. Zaloudek C, Kurman RJ: Functioning tumors of the ovary. In Diagnosis and Pathology of Endocrine Diseases, G. Mendelsohn (ed), Lippincott Co., Philadelphia, 1988, pp. 413-449.
47. Zaino RJ, Kurman RJ: Squamous differentiation in carcinoma of the endometrium: A critical appraisal of adenoacanthoma and adenosquamous carcinoma. Sem Diag Pathol 1988; 5:154-177.
48. Young RH, Kurman RJ, Scully RE: Proliferations and tumors of intermediate trophoblast of the placental site. Sem Diag Pathol 1988; 5:223-237.
49. Mazur MT, Kurman RJ: Trophoblastic Disease. In Diagnosis In Surgical Pathology, Sternberg, Antonioli, Carter, Eggleston, Oberman, Mills (eds). Raven Press, New York, 1989, pp1487-1502.
50. Yeh I-T, Kurman RJ: Editorial. Functional and morphologic expressions of trophoblast. Lab Invest 1989; 61:1-4.
51. Hesla JS, Kurman RJ, Rock JA: Histologic effects of oral contraceptives on the uterine corpus and cervix. Sem Reprod Endocrinol 1989; 7:213-219.
52. Crum C, Fu Y-S, Kurman RJ, Okagaki T, Twiggs, LB, Silverberg, SG: Editorial Board Symposium. Practical approach to cervical human papillomavirus-related intraepithelial lesions. Int J Gynec Pathol 1989; 8:388-399.
53. Yeh, I-T, Zaloudek C, Kurman RJ: Functioning tumors and tumor-like conditions of the ovary. In Principles and Practices of Endocrinology and Metabolism, K Becker et al (eds), J.B. Lippincott Co., Philadelphia 1990, pp 848-854.
54. Ambros, RA, Kurman, RJ: Current concepts in the relationship of HPV infection to the pathogenesis and classification of precancerous squamous lesions of the uterine cervix. Sem Diag Pathol 1990;7:158-172.
55. Schiffman MH, Kurman RJ, Barnes W, Lancaster WD: HPV infection and early cytological abnormalities in 3175 Washington, D.C. women. In Howley P, Broker T (eds) Papillomaviruses, Wiley-Liss Inc., 1990, p81-88.
56. Jenson AB, Kurman RJ, Lancaster WD: Tissue effects of and host response to human papillomavirus infection. In Human Papillomavirus Infection, Dermatologic Clinics, M.T. Goldfarb and Richard Reid (eds), vol 9, W.B. Saunders Co., Philadelphia, 1991, p203-209.
57. Kurman RJ, Malkasian GD Jr, Sedlis A, Solomon D: From Papanicolaou to Bethesda: The rationale for a new cervical cytologic classification. Obstet Gynecol 1991;77:779-782.
58. Kurman, RJ: The morphology, biology, and pathology of intermediate trophoblast: A look back to the present. Human Pathol 1991;22:847-855.
59. Kurman RJ: Pathology of trophoblast. In Pathology of Reproductive Failure, Kraus FT, Damjanov I, Kaufman N (eds), USCAP/Williams & Wilkins, Baltimore, 1991, 195-227.
60. Ambros RA, Kurman RJ: Tumors of the vulva. In Pediatric and Adolescent Gynecology, SE Koehler Carpenter and JA Rock (eds), Raven Press, New York, 1992, 353-363.
61. Perez CA, Kurman RJ, Stehman FB, Thigpen JT: Uterine cervix. In Principles and Practice of Gynecologic Oncology, WJ Hoskins, CA Perez, RC Young (eds), J.B. Lippincott Co, 1992, pp 591-662.
62. Kurman RJ, Trimble CL, Shah KV: Human papillomavirus and the pathogenesis of vulvar carcinoma. Current Opinion in Obstetrics and Gynecology, 1992;4:582-585.
63. Kiviat NB, Critchlow CW, Kurman RJ: Reassessment of the morphological continuum of cervical intraepithelial lesions: does it reflect different stages in the progression to cervical carcinoma? In The Epidemiology of Cervical Cancer and Human Papillomavirus, N Munoz, F Bosch, K Shah, H Mehens (eds), Lyon, International Agency for Research on Cancer, 1992, pp.59-66.
64. Kurman RJ, Norris HJ: Endometrium. In Pathology of Incipient Neoplasia, DE Henson and J Albores-Saavedra (eds), W.B. Saunders Co., Philadelphia, 1993, pp268-282.
65. Trimble CL, Trimble EL, Kurman RJ: Human Papillomavirus - Related Lesions of the Female Genital Tract. In Current Therapy in Oncology, JE Niederhuber (ed), Mosby-Year Book, Inc., St. Louis, Missouri, 1993, pp511-517.
66. Kurman RJ, Trimble CL: The behavior of serous tumors of low malignant potential: Are they ever malignant? Int J Gynecol Pathol 1993;12:120-127.
67. Kurman RJ: Cervical Cytology: Evaluation and Management of Abnormalities. ACOG Technical Bulletin, Number 183, August 1993 (replaces #81, October 1984).
68. Robboy SJ, Duggan MA, Kurman RJ: The Female Reproductive System. In Pathology, E Rubin, JL Farber (eds), J.B. Lippincott Company, Philadelphia, Pa, 1994, pp908-971.
69. Jones MW, Kurman RJ: Endometrial Hyperplasia. In Textbook of Gynecology, LJ Copeland (ed), W.B. Saunders Company, Philadelphia, Pa, 1993, pp889-895.
70. Mazur MT, Kurman RJ. Gestational Trophoblastic Disease. In Diagnostic Surgical Pathology, 2nd ed., S. Sternberg, D. Antonioli, D. Carter, S. Mills, H. Oberman, (eds). Raven Press Ltd., New York 1994, pp. 1975-1992.
71. Kurman RJ, Henson DE, Herbst AL, Noller KL, Schiffman MH. Interim Guidelines for Management of Abnormal Cervical Cytology. JAMA 1994;271:1866-1869.
72. Zaino RJ, Robboy SJ, Bentley R, Kurman RJ: Diseases of the Vagina. In Blaustein’s Pathology of the Female Genital Tract, 4th ed., RJ Kurman (ed), Springer-Verlag, Berlin, Heidelberg, New York, 1994, pp.131-184.
73. Wright TC, Kurman RJ, Ferenczy A: Precancerous lesions of the cervix. In Blaustein’s Pathology of the Female Genital Tract, 4th ed., RJ Kurman (ed), Springer-Verlag, Berlin, Heidelberg, New York, 1994,pp.229-278.
74. Wright TC, Ferenczy A, Kurman RJ: Carcinoma and other tumors of the Cervix. In Blaustein’s Pathology of the Female Genital Tract, 4th ed., RJ Kurman (ed), Springer-Verlag, Berlin, Heidelberg, New York, 1994, pp.279-326.
75. Kurman RJ, Mazur MT: Benign Diseases of the Endometrium. In Blaustein’s Pathology of the Female Genital Tract, 4th ed., RJ Kurman (ed), Springer-Verlag, Berlin, Heidelberg, New York, 1994, pp.367-410.
76. Kurman RJ, Norris HJ: Endometrial Hyperplasia and Related Cellular Changes. In Blaustein’s Pathology of the Female Genital Tract, 4th ed., RJ Kurman (ed), Springer-Verlag, Berlin, Heidelberg, New York, 1994, pp.411-438.
77. Kurman RJ, Zaino RJ, Norris HJ: Endometrial Carcinoma. In Blaustein’s Pathology of the Female Genital Tract, 4th ed., RJ Kurman (ed), Springer-Verlag, Berlin, Heidelberg, New York, 1994, pp.439-486.
78. Mazur MT, Kurman RJ: Gestational Trophoblastic Disease and Related Lesions. In Blaustein’s Pathology of the Female Genital Tract, 4th ed., RJ Kurman (ed), Springer-Verlag, Berlin, Heidelberg, New York, 1994, pp.1049-1096.
79. Robboy SJ, Kraus FT, Kurman RJ: Gross Description, Processing, and Reporting of Gynecologic and Obstetric Specimens. In Blaustein’s Pathology of the Female Genital Tract, 4th ed., RJ Kurman (ed), Springer-Verlag, Berlin, Heidelberg, New York, 1994, pp.1225-1246.
80. Wright TC Jr., Kurman RJ: A Critical Review of the Morphologic Classification Systems of Preinvasive Lesions of the Cervix: The Scientific Basis for Shifting the Paradigm. Papillomavirus Report 1994;5:175-182.
81. Robboy SJ, Duggan MA, Kurman RJ: The Female Reproductive System. Essential Pathology, 2nd ed., J.B. Lippincott Company, Phila., Pa. 1995;507-538.
82. Isacson C, Kurman RJ: The Bethesda System: A new classification for managing Pap smears. Contemporary Ob/Gyn 1995:40:67-74.
83. Yeh I-T, Zaloudek KC, Kurman RJ: Functioning tumors and tumor-like conditions of the ovary. In Principles and Practice of Endocrinology and Metabolism, 2nd ed., KL Becker (ed), J.B. Lippincott Co., Phila., Pa., 1995; 940-947.
84. Sherman ME, Kurman RJ. The role of exfoliative cytology and histopathology in screening and triage. In Human Papillomaviruses I, AT Lorincz and R Reid (eds). Obstet Gynec Clin N Amer, W.B. Saunders Co., Philadelphia, Vol. 23, 1996; 641-655.
85. Silva EG, Kurman RJ, Russell P, Scully RE. Symposium: Ovarian tumors of borderline malignancy. Int J Gynecol Pathol 1996; 15:281-302.
86. Sugarbaker PH, Ronnett BM, Archer A, Averbach AM, Bland R, Chang D, Dalton RR, Ettinghausen SE, Jacquet P, Jelinek J, Kislowe P, Kurman RJ, Shmookler B, Stephens AD, Steves MA, Stuart OA, White, S, Zahn CM, Zoetmulder FAN. Pseudomyxoma Peritonei Syndrome. In: Advances in Surgery, JL Cameron et al (eds). Vol 30. Mosby, St Louis, 1996; 253-280.
87. Stehman FB, Perez CA, Kurman RJ, Thigpen JT. Uterine Cervix. In: Principles and Practice of Gynecologic Oncology, 2nd ed., Hoskins WJ, Perez CA, Young RC (eds), Lippincott-Raven Publishers, Philadelphia, Pa., 1997.
88. Wu T-C, Kurman RJ. Analysis of cytokine profiles in patients with human papillomavirus-associated neoplasms. J Natl Cancer Inst 1997; 89:185-187.
89. Seidman JD, Ronnett BM, Kurman RJ. Why abandoning the borderline category of ovarian tumors is beneficial. Contemp Ob/Gyn 1997:66-84.
90. Shih I-M, Kurman RJ. New Concepts in trophoblastic growth and differentiation with medical application for the diagnosis of gestational trophoblastic disease. Verh Dtsch path 1997; 266-272.
91. Randall TC, Kurman RJ. Progestins are the treatment of choice for most patients with endometrial hyperplasia:A management scheme for endometrial hyperplasia based on age and desire for fertility. J Gynecol Tech 1997; 3:173-176.
92. Ronnett BM, Shmookler BM, Sugarbaker PH, Kurman RJ. Pseudomyxoma peritonei; new concepts in diagnosis, origin, nomenclature, and relationship to mucinous borderline (Low malignant potential) tumors of the ovary. Anatomic Pathology 1997 Vol 2, RE Fechner and PP Rosen (eds.), American Society of Clinical Pathologists, Chicago, Illinois, 1997; 197-226.
93. Sherman ME, Kurman RJ. Evolving concepts in endometrial carcinogenesis: Importance of DNA repair and deregulated growth. Hum Pathol 1998; 29:1035-1038.
94. Sherman ME, Kurman RJ. Intraepithelial carcinoma of the cervix: Reflections on half a century of progress. Cancer 1998; 83(11):2243-2246.
95. Robboy SJ, Duggan MA, Kurman RJ. The female reproductive system. In Pathology, E. Rubin and J. Farber (eds), Lippincott-Raven, Philadelphia, 1998, pp 963-1026.
96. Felix JC, Kurman RJ. Progestogen therapy in malignant tumors of the uterus and ovary. In Estrogens and Progestogens in Clinical Practice. IS Frazer, RPS Jansen, MI Whitehead (eds.), Churchill Livingstone, London, 1998, pp. 727-735.
97. Seidman JD, Kurman RJ. Tamoxifen and the endometrium. Int J Gynecol Pathol 1999; 18 (4):293-296.
98. Ronnett BM, Kurman RJ. Endometrial hyperplasia. In Textbook of Gynecology, 2nd Edition, Copeland (ed.), WB Saunders Co., Philadelphia, PA, 2000, pp. 1289-1297.
99. Seidman JD, Kurman RJ. Ovarian serous borderline tumors: A critical review of the literature with emphasis on prognostic indicators. Hum Pathol 2000; 31:539-557.
100. Seidman JD, Kurman RJ. Update on low malignant potential ovarian tumors. Oncology 2000; 14 (6):910-911.
101. Stehman FB, Perez CA, Kurman RJ, Thigpen JT. Uterine Cervix. In Principles and Practice of Gynecologic Oncology, Third ed., WJ Hoskins, CA Perez and RC Young (eds). Lippincott, Williams and Wilkins, Philadelphia, 2000, p 841-918.
102. Seidman JD, Ronnett BM, Kurman RJ. Evolution of the concept and terminology of borderline ovarian tumors. Curr Diagn Pathol 2000; 6:31-7.
103. Shih I-M, Kurman RJ. The pathology of intermediate trophoblastic tumors and tumor-like lesions. Int J Gynecol Pathol 2001; 20:31-47.
104. Ronnett BM, Sherman ME, Kurman RJ. Endometrium. In Pathology of Incipient Neoplasia, 3rd ed, DE Henson and J Albores-Saavedra (eds), Oxford University Press, N.Y., 2001, pp. 401-418.
105. Yeh I-T, Zaloudek C, Kurman RJ. Functioning tumors and tumor-like conditions of the ovary. In:Principles and Practice of Endocrinology and Metabolism 3rd ed. Becker KL (ed), Lippincott Williams and Wilkins, Philadelphia, 2001 p.1009-15.
106. Shih I-M, Kurman RJ. Editorial. Placental site trophoblastic tumor- Past as prologue. Gynecol Oncol 2001; 82:413-14.
107. Goldstein RB,Bree RL, Benson CB, Benacerraf BR, Bloss JD, Carlos R, Fleischer AC, Goldstein SR, Hunt RB, Kurman RJ, Kurtz AB, Laing FC, Parsons AK, Smith-Bindman R, Walker J. Evaluation of the woman with postmenopausal bleeding: Society of Radiologists in Ultrasound-Sponsored Consensus Conference Statement. J Ultrasound Med 2001; 20(1):1025-36.
108. Shih I-M, Kurman RJ. Molecular basis of gestational trophoblastic diseases. Curr Mol Med 2002; 2:1-12.
109. Zaino RJ, Robboy SJ, Kurman RJ. Diseases of the vagina. In Blaustein’s Pathology of the Female Genital Tract, 5th ed, RJ Kurman (ed), Springer-Verlag, NY, 2002, pp 151-206
110. Wright TC, Kurman RJ, Ferenczy A. Precancerous lesions of the cervix. In Blaustein’s Pathology of the Female Genital Tract, 5th ed, RJ Kurman (ed), Springer-Verlag, NY, 2002, pp 253-324.
111. Wright TC, Ferenczy A, Kurman RJ. Carcinoma and other tumors of the cervix. In Blaustein’s Pathology of the Female Genital Tract, 5th ed, RJ Kurman (ed), Springer-Verlag, NY, 2002, pp 325-382.
112. Sherman ME, Mazur MT, Kurman RJ. Benign diseases of the endometrium. In Blaustein’s Pathology of the Female Genital Tract, 5th ed, RJ Kurman (ed), Springer-Verlag, NY, 2002, pp 421-466.
113. Ronnett BM, Kurman RJ. Precursor lesions of endometrial carcinoma. In Blaustein’s Pathology of the Fermale Genital Tract, 5th ed, RJ Kurman (ed), Springer-Verlag, NY, 2002, pp 467-500.
114. Ronnet BM, Zaino RJ, Hedrick Ellenson L, Kurman RJ. Endometrial carcinoma. In Blaustein’s Pathology of the Female Genital Tract, 5th ed, RJ Kurman (ed), Springer-Verlag, NY, 2002, pp 501-560
115. Seidman JD, Russell P, Kurman RJ. Surface epithelial tumors of the ovary. In Blaustein’s Pathology of the Female Genital Tract, 5th ed, RJ Kurman (ed), Springer-Verlag, NY, 2002, pp 791-904.
116. Shih I-M, Mazur MT, Kurman RJ. Gestational trophoblastic disease and related lesions. In Blaustein’s Pathology of the Female Genital Tract, 5th ed, RJ Kurman (ed), Springer-Verlag, 2002, pp 1193-1250.
117. Robboy SJ, Kraus FT, Kurman RJ. Gross description, processing, and reporting of gynecologic and obstetric specimens. In Blaustein’s Pathology of the Female Genital Tract, 5th ed, RJ Kurman (ed), Springer-Verlag, NY, 2002, pp1319-1346.
118. Seidman JD, Kurman RJ. Treatment of micropapillary serous ovarian carcinoma (the aggressive variant of serous borderline tumors). Cancer Aug 15, 2002; 95(4):675-6.
119. Seidman JD, Ronnett BM, Kurman RJ. Pathology of borderline (low malignant potential) ovarian tumors. Obstetrics and Gynaecology (Bailliere Tindall) 2002; 16(4):499-512.
120. Seidman JD, Kurman RJ. Pathology of ovarian carcinoma. In Current Concepts in Ovarian Cancer, ML Disis (ed) Hematology Oncology Clinics of North America 2003; 17:909-925.
121. Shih Ie-M, Kurman RJ. Ovarian Tumorigenesis: A proposed model based on morphological and molecular genetic analysis. Amer J Pathol 2004; 164(5):1511-1518.
122. Silverberg SG, Bell DA, Kurman RJ, Seidman JD, Prat J, Ronnett BM, Copeland L, Silva E, Gorstein F and Young RH. Borderline ovarian tumors: Key points and workshop summary. Hum Pathol 2004; 35:910-917.
123. Bell DA, Longacre TA, Prat J, Kohn EC, Soslow RA, Ellenson LH, Malpica A, Stoler MH and Kurman RJ. Serous borderline (low malignant potential, atypical proliferative) ovarian tumors: Workshop perspectives. Hum Pathol 2004; 35:934-948.
124. Kurman RJ, Seidman JD, Shih,I-M. Serous borderline tumours of the ovary. Histopathology 2005; 47:310-318.
125. Shih I-M, Kurman RJ. Molecular pathogenesis of ovarian borderline tumors: New insights and old challenges. Clin Cancer Res 2005;11:7273-7279.
126. Kurman RJ, Shih IM. Pathogenesis of ovarian cancer: Lessons from morphology and molecular biology and their clinical implications. Intl J Gynecol Pathol 2008; 27:151-160.
127. Kurman RJ, Visvanathan K, Roden R, Wu TC, Shih I-M. Early detection and treatment of ovarian cancer: shifting from early stage to minimal volume of disease based on a new model of carcinogenesis. Am J Obstet Gynecol 2008; 198(4):351-356.
128. Shih I-M, Mazur MT, Kurman RJ. Gestational trophoblastic disease. In Sternberg’s Diagnostic Surgical Pathology 5th Edition, Milles SE (ed) Lippincott, Williams & Wilkins, 2009 pp. 2049-2070.
129. Kurman RJ, Shih I-M. The origin and pathogenesis of epithelial ovarian cancer: A proposed unifying theory. Am J Surg Pathol 2010; 34:433-443.
130. Gross AL, Kurman RJ, Vang R, Shih I-M, Visvanathan K. Precursor lesions of high-grade serous ovarian carcinoma: Morphlogical and molecular characteristics. Journal of Oncol 2010;2010: 12625 (online).
131. Kurman RJ, McConnell TG. Precursors of endometrial and ovarian carcinoma. Virchows Arch 456:1-12, 2010.
132. Kurman RJ, McConnell TG. Characterization and comparison of precursors of ovarian and endometrial carcinoma: Parts I and II. Int J Surg Pathol 18:1815-1895, 2010.
133. Zaino RJ, Nucci M, Kurman RJ. Diseases of the vagina. In Blaustein’s Pathology of the Female Genital Tract, 6th ed, RJ Kurman, L Hedrick Ellenson, BM Ronnett (eds), Springer-Verlag, NY, 2011, pp 105-154
134. Wright TC, Ronnett BM, Kurman RJ, Ferenczy A. Precancerous lesions of the cervix. In Blaustein’s Pathology of the Female Genital Tract, 6th ed, RJ Kurman, L Hedrick Ellenson, BM Ronnett (eds), Springer-Verlag, NY, 2011, pp 193-252.
135. Witkiewicz AK, Wright TC, Ferenczy A, Ronnett BM, Kurman RJ. Carcinoma and other tumors of the cervix. In Blaustein’s Pathology of the Female Genital Tract, 6th ed, RJ Kurman, L Hedrick Ellenson, BM Ronnett (eds), Springer-Verlag, NY, 2011, pp 253-304.
136. Hedrick Ellenson L, Ronnett BM, Kurman RJ. Precursor lesions of endometrial carcinoma. In Blaustein’s Pathology of the Fermale Genital Tract, 6th ed, RJ Kurman , L Hedrick Ellenson, BM Ronnett (eds), Springer-Verlag, NY, 2011, pp 359-392.
137. Hedrick Ellenson L, Ronnet BM, Soslow RA, Zaino RJ, Kurman RJ. Endometrial carcinoma. In Blaustein’s Pathology of the Female Genital Tract, 6th ed, RJ Kurman, L Hedrick Ellenson, BM Ronnett (eds), Springer-Verlag, NY, 2011, pp 393-452
138. Seidman JD, Cho KR, Ronnett BM, Kurman RJ. Surface epithelial tumors of the ovary. In Blaustein’s Pathology of the Female Genital Tract, 6th ed, RJ Kurman, L Hedrick Ellenson, BM Ronnett (eds), Springer-Verlag, NY, 2011, pp 679-784.
139. Shih I-M, Mazur MT, Kurman RJ. Gestational trophoblastic disease and related lesions. In Blaustein’s Pathology of the Female Genital Tract, 6th ed, RJ Kurman, L Hedrick Ellenson, BM Ronnett (eds), Springer-Verlag, 2011, pp 1075-1136.
140. Kurman RJ, Shih I-M. Molecular pathogenesis and extraovarian origin of epithelial ovarian cancer – Shifting the paradigm. Human Pathol 2011;42:918-931
141. Banet N, Shih I-M, Kurman RJ. The origin and pathogenesis of epithelial ovarian cancer. In Textbook of Gynaecological Oncology, A Ayhan, N Reed, M Gultekin, P Dursun (eds) Gunes Publishing, Turkey, 2012, pp 422-431
142. Kuhn E, Kurman RJ, Shih I-M. Ovarian cancer is an imported disease: Fact or fiction. Curr Obstet Gynecol Rep, 2012;1:1-9
Books:
1. Kurman RJ (ed): Blaustein’s Pathology of the Female Genital Tract. 3rd ed. Springer-Verlag, Berlin, Heidelberg, New York, 1987.
2. Silverberg SG, Kurman RJ: Atlas of Tumor Pathology. Tumors of the Uterine Corpus and Gestational Trophoblastic Disease, Third Series, Fascicle 3, Armed Forces Institute of Pathology, Washington, D.C., 1992.
3. Kurman RJ, Norris HJ, and Wilkinson E: Atlas of Tumor Pathology. Tumors of the Cervix, Vagina and Vulva, Third Series, Fascicle 4, Armed Forces Institute of Pathology, Washington, D.C., 1992.
4. Kurman RJ, Solomon D: The Bethesda System for Reporting Cervical/Vaginal Cytologic Diagnoses. Definitions, Criteria, and Explanatory Notes for Terminology and Specimen Adequacy. Springer-Verlag, New York, 1994.
5. Scully RE, Bonfiglio TA, Kurman RJ, Silverberg SG, Wilkinson EJ. World Health Organization International Histological Classification of Tumors. Histological Typing of Female Genital Tract Tumours, 2nd ed., Springer-Verlag, Berlin, 1994.
6. Kurman RJ (ed): Blaustein’s Pathology of The Female Genital Tract. 4th ed., Springer-Verlag, New York, 1994.
7.Mazur MT, Kurman RJ. Diagnosis of Endometrial Biopsies and Curettings. A Practical Approach, Springer-Verlag, New York, 1995.
8. Kurman RJ (ed): Blaustein’s Pathology of the Female Genital Tract. 5th ed, Springer-Verlag, New York, 2002.
9. Mazur MT, Kurman RJ. Diagnosis of Endometrial Biopsies and Curettings. A Practical Approach, Springer-Verlag, 2nd edition, New York, 2005
10. Giordano A, Bovicelli A, Kurman RJ. Molecular Pathology of Gynecologic Cancer. Humana Press, Totowa, New Jersey, 2007
11. Kurman RJ, Ronnett BM, Sherman ME and Wilkinson E: Atlas of Tumor Pathology. Tumors of the Cervix, Vagina and Vulva, Fourth Series, Fascicle 13, Armed Forces Institute of Pathology, Washington, D.C., 2010.
12. Kurman RJ, L Hedrick Ellenson, BM Ronnett (eds): Blaustein’s Pathology of the Female Genital Tract. 6th ed, Springer-Verlag, New York, 2011.
责任编辑：abin 本站欢迎原创文章投稿，来稿一经采用稿酬从优，投稿邮箱tougao@ipathology.com.cn
相关阅读
数据加载中
我要评论
热点导读
-
淋巴瘤诊断中CD30检测那些事（五）
强子 华夏病理2022-06-02 -
【以例学病】肺结节状淋巴组织增生
华夏病理 华夏病理2022-05-31 -
这不是演习-一例穿刺活检的艰难诊断路
强子 华夏病理2022-05-26 -
黏液性血性胸水一例技术处理及诊断经验分享
华夏病理 华夏病理2022-05-25 -
中老年女性，怎么突发喘气困难？低度恶性纤维/肌纤维母细胞性肉瘤一例
华夏病理 华夏病理2022-05-07
在线投稿
共0条评论